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ABSTRACT 
Porcine reproductive and respiratory syndrome (PRRS) is considered 
one of the major causes of economic losses to swine producers. The causative 
agent, the PRRS virus (PRRSV), has been recently isolated, partially 
characterized and included into a new group of virus tentatively named 
arteriviruses. Notable biological features of PRRSV are its ability to infect 
swine alveolar macrophages and induce persistent infection. In vitro, PRRSV 
replication is restricted to few continuous cell lines, none of which are of 
porcine origin. Thus, the interaction of PRRSV with cells and the major 
structural proteins of the virus have been investigated in these studies, 
aiming to better understand the mechanisms governing cell tropism and 
replication in cells. 
Several cells of different animal origin were used to determine the 
mechanism of resistance to infection. PRRSV replication was restricted at 
several distinct steps: first, in most cells tested, resistance correlated with 
absence of virus binding to cells, indicating that the absence of viral receptors 
on the target cell was the major determinants of cell tropism; second, Vero 
cells bound and internalized PRRSV almost as efficientiy as the susceptible 
cell line MARC-145 but were defective in virus uncoating; third, a mechanism 
following virus entry might have also inhibited virus replication in that 
transfection of cells with viral RNA did not induce progeny virus in all cells 
tested. 
The mechanism of virus uptake into MARC-145 cells was also 
investigated. By analyzing the effect of lysosomotropic drugs on PRRSV 
infection of cells and electron miaoscopic analysis of cell-bound viruses, it 
was determined that PRRSV entered cells by a microfilament-dependent, 
receptor-mediated endocytic mechanism and that a low pH step was required 
during the initial stages of infection. 
vii 
The major structural proteins of PRRSV (E, M and N) were cloned and 
expressed in a baculovirus system, in an attempt to identify the viral 
protein(s) that mediated virus binding to cell. Binding on none of the 
proteins could be demonstrated by several binding assays. Nonetheless, the 
recombinant proteins were used to induce monospecific polyclonal sera that 
were used to detect the proteins in mammalian cells following virus 
infection. Using indirect fluorescent antibody staining of infected cells, 
proteins E and M were found circumscribing the cellular nuclear area, 
whereas the N protein was located throughout the entire cellular cytoplasm. 
In conclusion, there are multiple mechanism that might restrict 
PRRSV replication in cells. However, following binding to permissive cells, 
PRRSV enters through the endocytic pathway and, during the replication 
process, the major viral structural proteins accumulate at specific cellular 
compartments. 
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CHAPTER 1. GENERAL INTRODUCTION 
Porcine reproductive and respiratory syndrome (PRRS) has been 
recognized as a major cause of financial losses to the swine industry. The 
causative agent of PRRS, the PRRS virus (PRRSV) causes a flu-like syndrome in 
pigs of all ages and reproductive failure in pregnant females (reviewed by Done 
et al., 1996). Although PRRSV has been isolated and partially characterized just 
recently (Wensvoort et al., 1991; Benfield et al., 1992; Collins et al., 1992; 
Conzelmann et al., 1993; Meulenberg et al., 1993a), serologic retrospective studies 
indicated that PRRSV was circulating in the swine population since the late 
1980s (Owen et al., 1992). Initially, because no etiologic agent could be 
incriminated as the cause of PRRS, a variety of names and acronyms were used 
to designate outbreaks of respiratory problems and reproductive failure (Goyal et 
al., 1993). 
Following the successful isolation and replication of PRRSV in cells in 
culture (porcine macrophages or the proprietary cell line CRL 2621), the 
syndrome was experimentally reproduced and the virus reisolated according to 
Koch's postulates (Wensvoort et al., 1991; Collins et al., 1992). In addition, the 
biochemical, physical and molecular properties of this new agent indicated its 
close relationship with other already known viruses, namely equine arteritis 
virus (EAV), lactate dehydrogenase-elevating virus (LDV) and simian 
hemorrhagic fever virus (SHFV; Plagemann and Moennig, 1992; Conzelmann et 
al., 1993; Meulenberg et al., 1993a). These viruses have since been classified in a 
new group of viruses, the arteriviruses. Porcine reproductive and respiratory 
syndrome virus is an enveloped virus with a diameter in the range of 40 to 80 
nm (Benfield et al., 1992; Mardassi et al., 1994a). The envelope contains a 
nonglycosylated membrane protein (M), one major glycosylated protein (E) and 
several other minor glycoproteins (Drew et al., 1995; Meulenberg et al., 1995a). 
Internally, arteriviruses contain an icosahedral capsomere of approximately 
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25 to 35 run in diameter. The genome of arteriviruses consists of a single-
stranded RNA molecule of positive molarity, which is polyadenylated at the 3' 
end; during replication in cells, arteriviruses induce the synthesis of several 
subgenomic mRNA molecules that form a nested set of 3' end co-terminal 
molecules (Plagemann, 1996). 
Because of the economic impact of PRRS in the swine population, basic 
and applied research has been intensified since the isolation of PRRSV in an 
attempt to understand the virus and the syndrome it causes. Although most 
research is still focused on virus pathogenicity, understanding of the molecular 
and biological aspects of the virus is rapidly expanding. The complete nucleotide 
sequence has been determined for at least one isolate (Meulenberg et al., 1993a). 
A number of other isolates have been partially sequenced; conserved and 
variable regions of the genome have been identified (Conzelman et al., 1993; 
Meng et al., 1994,1995a, 1995b; Morozov et al., 1995; Murtagh et al., 1995; Kapur et 
al., 1996; Suarez et al., 1996b). The viral structural proteins have been at least 
partially characterized and assigned to a specific open reading frame (ORF) on the 
viral genome. The viral nudeocapsid protein (N) has a molecular mass (Mr) of 
approximately 15 K and is encoded by ORF 7; the matrix or membrane (M) 
protein has a Mr of approximately 19 K and is encoded by ORF 6; both the N and 
M proteins share common epitopes among all isolates (Mardassi et al., 1995; 
Meulenberg et al., 1995a). The viral major envelope glycoprotein (E) has a Mr of 
approximately 25 K and is encoded by ORF 5 (Mardassi et al., 1995; Meulenberg et 
al., 1995a). Neutralizing epitopes have been found in assodation with the 
glycoprotein E (Persch et al., 1995), which is also responsible for cell death (Suarez 
et al., 1996a), suggesting that this glycoprotein plays a major role in virus 
pathogenidty. The viral envelope glycoproteins Gp2, 3 and 4 have recentiy been 
detected in purified virions and have been assigned to ORFs 2,3 and 4, 
respectively (Drew et al., 1995; Meulenberg et al., 1995b). Although as many as 
five structural proteins have been detected in the viral envelope, none of them 
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has yet been associated with binding to receptors on target cells. 
Following outbreaks of PRRS in several regions of the world and an 
intensive search for the etiologic agent of the syndrome, the virus was finally 
isolated in porcine alveolar macrophages (Wensvoort et al., 1991) and a 
proprietary established cell line (CRL 2621, Benfield et al., 1992; Collins et al., 
1992). Currently, additiorial established cell lines, MARC-145 (Kim et al., 1993) 
and CRL 11171 (Meng et al., 1996a) are also used for in vitro propagation of 
PRRSV. Although most cells available (even porcine cells) are refractive to 
PRRSV replication, the mechanisms that restrict virus replication in these cells 
have not been studied. Furthermore, the pathway of virus entry into susceptible 
cells and the viral and cellular structures that mediate virus binding and 
internalization is yet to be determined. Information of these important steps of 
virus infection of cells is still awaited even for other arteriviruses. Determining 
the initial steps of virus infection of cells and finding and characterizing the 
molecules involved would greatly improve our understanding of the PRRS 
complex. 
Thesis Organization 
This dissertation is organized in an alternate format. It begins with an 
abstract, followed by general introduction to the dissertation, literature review 
and a statement of the problem. Three manusaipts that desdbe the 
experimental work have been included. The first manuscript 'Torcine 
reproductive and respiratory sjmdrome virus enters cells through a low pH-
dependent endocytic pathway" has been published in Virus research volume 42, 
137-147. The second manuscript is entitled "Cellular membrane factors are the 
major determinants of porcine reproductive and respiratory syndrome virus 
tropism" and will be submitted to Virus Research. The third manuscript, 
entitled "Baculovirus expression and immunological characterization of the 
4 
major structural proteins of porcine reproductive and respiratory syndrome 
virus" will be submitted to Veterinary Microbiology. I am the principal 
investigator and senior author of all the manuscripts. The third manuscript is 
followed by general conclusions of the experimental work, and a list of all 
references cited in the general introduction, literature review and general 
conclusions, followed by the acknowledgments and vita section. 
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CHAPTER 2. LITERATURE REVIEW 
Historic and economic impact of PRRS 
Outbreaks of an unusual syndrome characterized by respiratory distress in 
association with reproductive failure were observed in the pig population of 
several states of the United States of America in the late 1980s (Keffaber, 1989). 
The syndrome became known as swine reproductive failure sjmdrome, 
SMEDI-like syndrome, swine infertility and respiratory syndrome (SIRS), porcine 
epidemic abortion and respiratory syndrome (PEARS), blue ear disease and, 
because no agent could be associated with it, as "mystery swine disease" 
(reviewed by Goyal, 1993). Similar outbreaks were first observed in Europe in 
1990 (Lindhaus and Lindhaus, 1991) where it became widely distributed and 
known as infectious late abortion of pigs, enzootic late abortion of pigs and 
abortus blauw among others. A variety of microorganisms were tentatively 
incriminated as the putative cause of the syndrome, but they were not 
consistently isolated from diseased animals. 
The association of a microorganism with the syndrome was not reported 
until 1991, when scientists at the Central Veterinary Institute of Lelystad, in the 
Netherlands, isolated a virus from naturally infected animals (Wensvoort et al., 
1991) and experimentally reproduced the disease (Terpstra et al., 1991), fulfilling 
Koch's postulates. This virus, yet vmknown in the swine population, was 
isolated using porcine alveolar macrophages and designated Lelystad virus (LV). 
In the United States, a similar virus was isolated in a continuous cell line and 
designated swine infertility and respiratory syndrome (SIRS) virus isolate 
VR 2332 (Benfield et al., 1992; Collins et al., 1992). In the first international 
symposium on the disease, held in 1992, the name porcine reproductive and 
respiratory syndrome (PRRS) was chosen to designate the syndrome 
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and the etiologic agents as PRRS virus (PRRSV) (Meredith, 1992; Morrison et 
al., 1992). Based on phenotypic and genotypic characteristics, PRRSV has been 
tentatively classified in the newly proposed arterivirus group, along with lactate 
dehydrogenase-elevating virus (LDV) of mice, equine arteritis virus (EAV) and 
simian hemorrhagic fever virus (SHFV) (Conzelmann ef al., 1993; Meulenberg 
et al., 1993a: Plagemann and Moennig, 1992). Although the European and U.S. 
prototype isolates are designated LV and PRRSV, respectively, and antigenically 
related, they are considered different genotypes of the same virus (Wensvoort et 
al., 1992a; Meng et al., 1995b). A recent serologic siurvey detected antibodies to 
PRRSV in 80% of the farms; furthermore, 50% of the positive farms had 
antibodies to both the LV and the US reference strain ATCC VR 2332 (Bautista et 
al., 1993). Thus, based on this observation, it is likely that PRRSV will become 
enzootic in the swine population. Currently, the presence of the virus and/or 
the disease has been reported in most pork producing countries of the world 
(Goyal, 1993; Meredith, 1993). 
Porcine reproductive and respiratory sjmdrome has caused substantial 
economical losses to swine producers and to the swine industry. Outbreaks of 
PRRS cause a 20-30% increase in the rate of stillborn animals and loss of 1.5-2.0 
piglets per sow per year (Goyal, 1993). Losses of up to $500/sow year have been 
reported during acute outbreaks of PRRS in the U.S.A. (Poison et al., 1990). A 
study on the economic impact of PRRSV on the Canadian swine industry 
indicated direct financial losses of $5-10/pig produced (Sanford and Moore, 1995). 
In the Netherlands, the estimated economical loss of 91 herds averaged £65/sow 
year, which represented approximately 55% of the pig farm income (Borrower et 
al., 1994). During an outbreak of PRRS in a large swine operation in Poland, 
75.56% of piglets were stillborn or died before weaning (Pejsak and Stadejek, 
1995). In addition, indirect costs with dead animals, treatments and growth 
retardation because of persistent infection contribute to an increase in the total 
production cost of animals. Consequently, many governmental and private 
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funded laboratories are dedicating great efforts towards understanding the 
disease, designing diagnostic methods and developing vaccines and 
mariagement procedures to detect and control the spread of the virus and 
prevent further outbreaks. 
Etiologic agent 
Physico-chemical properties of the virus 
The presence of a lipid envelope in PRRSV particles was demonstrated by 
treatment of virus particles with chloroform, which reduced virus infectivity by 
greater than 99.99% (Wensvoort et al., 1991; Benfield et al., 1992). The virus has a 
low buoyant derisity, which is approximately 1.18 - 1.19 g/ml in cesium chloride 
gradients and 1.18 - 1.23 g/ml in suaose gradients (Benfield et al., 1992; Mardassi 
et al., 1994a; Meng et al., 1994), which also indicates the presence of an envelope. 
Electron microscopy observation of purified virions indicated that PRRSV is a 
spherical, enveloped virus with a diameter range of 40 to 80 run and a capsid core 
of approximately 25 to 35 run (Benfield et al., 1992; Wensvoort et al., 1992b; 
Kuwahara et al., 1994; Mardassi et al., 1994a;). The virus does not agglutinate red 
blood cells of several animeil species and is inactivated when incubated at 37°C 
for 48 hr, or 56°C for 45 minutes, and in media with pH lower than 5 or greater 
than 7 (Wensvoort et al., 1991; Benfield et al., 1992; Van Alstine et al., 1993; 
Bloemraad et al., 1994). Virus viability is maintained in serum at suboptimal 
temperatures (25°C) but not in tissue samples (Van Alstine et al., 1993). In 
contrast, the virus infectivity remains unchanged at 4°C for up to one month, or 
at -70°C for up to four months (Benfield et al., 1992). In meat refrigerated at 4°C, 
virus, if present, might be recovered for up to 48 hr. (Bloemraad et al., 1994). 
Determination of virus viability in fomites commonly foimd in farms indicated 
that virus viability is rapidly lost in the presence of several materials including 
maize, swine starter feed and denim cloth; virus viability, at 25 to 27°C, was 
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maintained for one day on alfalfa, wood shavings, straw, plastic, boot rubber, 
stainless steel and up to nine and eleven days in well and city water, respectively 
(Pirtle and Beran, 1996). 
Viral gpnnme organization and replication 
Initial investigation using inhibitors of nucleic add synthesis during viral 
replication in cells indicated that PRKSV contained an RNA genome (Benfield et 
al., 1992). In addition, gel electrophoresis of cytoplasmic RNA extracted from 
LV-infected or non-infected macrophages identified a LV-specific RNA band that 
migrated slower than the 12.3 Kb RNA of hog cholera virus (Werisvoort et al., 
1992b). Later, it was demonstrated that the genome of PRRSV was composed of a 
single-stranded, non-segmented RNA molecule of positive sense, with 
approximately 15,000 nucleotides in length (Conzelmarm et al., 1993; Meulenberg 
et al., 1993a). An outline of the virus genome organization is depicted in figiire 
1. Computer analysis of the complete nucleotide sequence of the LV identified 
eight partially overlapping open reading frames (ORFs): beginning at the 5' end, 
the first ORF initiates at nucleotide 212 and comprises approximately 80% of the 
viral genome (nucleotide 1 to 11772); this ORF is denoted ORFla/ORFlb because 
ORFlb is in the -1 reading frame in relation to ORFla, and it is thought to 
encode for the RNA replicase protein; ORFs 2 to 6 are located at the 3' end of the 
genome (nucleotide 11786 to 14595) and encode for potential viral structural, 
membrane-associated proteins; ORF 7 (nucleotide 14588 to 14971) encodes for the 
viral nucleocapsid protein (Corizelmann et al., 1993; Meulenberg et al., 1993a). 
The 3' end noncoding sequence following the stop codon of ORF 7 is 114 
nucleotide in length and is followed by a poly-adenylated (poly-A) tail of 
approximately 20 nucleotide (Conzelmarm et al., 1993; Meulenberg et al., 1993a). 
Several interesting features were observed in the LV genome that 
established its relationship with other already known viruses (EAV and LDV) 
Kb 
0 1 2 3 4 5 6 7 8 9 10 II 12 13 14 15 
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I M (19 KDa) 1.4-
N (15 KDa) 0.9 
Figure 1. Organization of PRRSV genome (Leiystad virus, modified from Meulenberg et 
al., 1993). The complete viral genome of 15 Kb is represented on scale. Open 
boxes represent ORFs 1 to 7. The black squares indicates the 5' leader, and An 
represents the poly (A) tail present in each RNA (1 to 7). Each structural 
protein is indicated at the left of the RNA from which it is tought to be 
translated. gP = glycoprotein. 
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and allowed its classification. The LV nucleotide sequence at the overlap region 
of ORFla/ORFlb revealed the presence of a slippery sequence (UUUAAA) and a 
sequence that might form an RNA pseudoknot, as previously observed with 
EAV (Brierley et al., 1989). The slippery sequence is located immediately 
upstream of the UAG stop codon of ORFla and is followed downstream by a 
potential stem-loop forming sequence (Meulenberg et al., 1993a). The amino acid 
sequence analysis of ORFla of LV revealed the presence of hydrophobic regions, 
cysteine rich domaiiis and a putative serine protease consensus sequence 
(Meulenberg et al., 1993a) similar to those observed with the torovirus Berne 
virus (BEV, Snijder et al., 1990) and with EAV (den Boon et al., 1991a). The 
predicted amino acid sequence of ORFlb is more conserved than ORFla among 
LV, EAV, LDV and BEV (Meulenberg et aL, 1993a). The ORFlb of this viruses 
share four characteristic domains: 1) the RNA polymerase motif with the core 
sequence S/GDD; 2) a cysteine- and histidine-rich domain; 3) a helicase motif and 
nucleoside triphosphate binding site; and 4) a conserved domain of yet unknown 
function (Meulenberg et al., 1993a). 
Analysis of viral-encoded RNA firom infected cells indicated the presence 
of several viral transcripts (Conzelmann et aL, 1993; Meulenberg et al., 1993a; 
Meng et al., 1994, 1996b). By using probes homologous to different parts of the 
genome, it become evident that most viral transcripts were unique to the 3' end 
of the genome, as was observed with LDV and EAV (van Berlo et al., 1986; Spaan 
et aL, 1988; de Vries et al., 1990; Kuo et al., 1991). A probe homologous to the 3' 
end of the viral genome detect the viral genomic RNA and six or seven 
subgenomic mRNA molecules of decreasing molecular weight size (Conzelman 
et al., 1993; Meulenberg et al., 1993a; Meng et al., 1994,1996b). Each subgenomic 
mRNA is thought to be transcribed from one ORF of the viral genome. Thus, 
the largest transcript is similar in size to the viral genome, and each subgenomic 
mRNA is shorter than the previous by the length corresponding to the ORF that 
precedes it. The size of each transcript in decreasing order is 15,3.3,2.7,2.2,1.7, 
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1.1, and 0.7 kilobases (Kb), for RNAs 1 to 7, respectively (Conzelmarm et al., 1993; 
Meulenberg et al., 1993a), Isolates expressing 7 subgenomic RNAs contain an 
extra mRNA from an ORF located between ORF 3 and 4, which has been 
designated mRNA 3.1 (Meng et al., 1996b). Although the larger viral transcripts 
are polycystronic, i.e., contain more than one ORF, only the first ORF (most 5') is 
thought to be translated into a protein. All viral subgenomic mRNAs contain 
the same sequence at the 5' end (>200 nucleotides) called leader sequence that is 
identical to the 5' end of the genomic RNA (Conzelmarm et al., 1993; Meulenberg 
et al., 1993a, 1993b). It has been hypothesized that the generation of subgenomic 
mRNA molecules, in this type of genome organization, follows a leader RNA-
primed mechanism (Baric et al., 1983,1985; Makino et al., 1986; Baker and Lai, 
1990) in which the leader sequence is transcribed from the 3' end of the genome-
sized negative strand RNA, dissociates from the template and then reattaches to 
the RNA template at intergenic regions located downstream on the genome, to 
function as a primer for the s)mthesis of the subgenomic mRNA molecules . 
The sequence of the leader-body junction (i.e., where the leader sequence 
becomes attached to the mRNA) of six subgenomic RNAs of LV share a common 
motif of six nucleotide that are (U/A) (C/U/A) (A/G) ACC; the first three 
nucleotide are heterogeneous, whereas the last three are identical in all mRNAs 
(Meulenberg et al., 1993b). Currently, there is no evidence that priming of the 
body leader sequence is required for transcription. In addition, although the 
leader-primed hypothesis is a reasonable model to explain the generation of viral 
mRNAs, it is not known if a short sequence of up to six nucleotide is enough for 
efficient binding of the leader and priming for the synthesis of new RNA 
molecules. Other mechanisms for the generation of subgenomic RNA have 
been put forward, as for example splicing of mRNA molecules from genome-
sized precursors (van Berlo et al., 1986), and the presence of subgenomic-sized 
negative strand RNA molecules that would originate positive strand mRNAs 
(de Vries et al., 1990). There are some data supporting these two mechanisms. 
12 
but the RNA leader priming medianism is currently most widely accepted. 
Viral proteins 
The initial investigation of viral-encoded proteins was performed by 
immunoblot using infected cells lysates and polyclonal antisera from a pig 
experimentally infected with PRRSV. Three proteins of molecular mass (Mr) of 
15,19 and 26 K were identified and, based on similarities with LDV and EAV, 
were designated nucleocapsid (N), nonglycosylated membrane (M) and 
glycosylated envelope (E) proteins, respectively (Nelson et al., 1993; Nelson et al., 
1994). Recently, proteins of 29, 31-35 and 40-50 K were found in association with 
purified virions (Meulenberg et al., 1995b). Currently, no protein product has 
been detected from ORFla/ORFlb; however, based on nucleotide sequence and 
deduced amino add sequence, it is thought that this ORF encodes for the RNA 
replicase protein (Conzelmann et al., 1993; Meulenberg et al., 1993a). 
The N protein 
Computer analysis of the LV ORF 7 indicated that it encodes for a basic 
protein of 128 amino acids (Conzelmarm et al., 1993; Meulenberg et al., 1993a). 
A protein of 123 amino adds is predicted from the ORF 7 of the U. S. and 
Canadian isolate of PRRSV (Meng et al., 1994; Mardassi et al., 1995; Murtaugh et 
al., 1995). The calculated Mr of 13.8 K for all isolates approximates the 15 K of the 
N protein as estimated from its migration in polyacrylamide gel electrophoresis 
(PAGE) following in vitro transcription and translation studies (Drew et al., 1995; 
Mardassi et al., 1995; Meulenberg et al., 1995a) or baculovirus expression 
(Meulenberg et al., 1995c). Recently, Bautista et al (1996) analyzed radioactively 
labelled purified virion preparations and demonstrated that the 15 K protein is 
indeed the nucleocapsid protein. A peptide of approximately 13.5 K also has been 
detected by SDS-PAGE of purified virions, and it is thought to be a subproduct of 
the nudeocapsid (Meulenberg et al., 1995a; Mardassi et al., 1996). The N protein 
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is readily detected by inimunoblot using sera from infected animals. Indeed, the 
immimological response of infected cinimals is initially directed to a 15 K protein 
and subsequently to other viral structural proteins in a time-dependent fashion 
(Nelson et al., 1993; Yoon et al., 1995b). Monoclonal antibodies to the N protein 
identified conserved epitopes among all isolates (North American and 
European) but also unique epitopes present either in the North American or 
European isolates (Nelson et al., 1993). 
The M protein 
Hydrophilidty plots of the deduced amino acid sequence of the M protein 
of PRRSV indicated that it contains three membrane spaiining domains 
(Conzelmarm et al., 1993; Meulenberg et al., 1993a) similarly to the coimterpart 
protein of LDV and EAV (Godeny et al., 1990; den Boon et al., 1991b; Kuo et al., 
1992). The M protein has a calculated Mr of 19 K and is expressed from the viral 
ORF 6; it contaiiis 174 or 173 amino adds for the North American or European 
isolates, respectively (Conzelmarm et al., 1993; Meulenberg et al., 1993a; Meng et 
al., 1994). In vitro transcription and franslation studies of ORF 6 identified a 
nonglycosylated protein of 18 to 19 K (Drew et al., 1995; Mardassi et al., 1995; 
Meulenberg et al., 1995a). Although the M protein is likely located in the viral 
envelope and contains a relatively large external domain, it is highly coriserved 
among North American isolates and the most conserved structural protein 
between North American and European isolates (Meng et al., 1995b; Murtaugh et 
al., 1995). Monodonal antibodies to the M protein identified common and 
unique epitopes among North American and European isolates (de Kluijver et 
al., 1995). Blots of cell lysates reacted with convalescent sera from infected 
animals demonstrated that the M protein is highly antigenic and elidts a 
detectable antibody response at approximately 10 days following infection (Yoon 
et al., 1995b; Loemba et al., 1996). 
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The E glycoprotein 
The deduced amino acid sequence of PRRSV ORF 5 indicated that this 
protein contains 200 amino acids (201 for the European isolate), 2 to 4 potential 
N-glycosylation sites, a signal peptide of 31 amino add and a Mr of 22.4 K 
(Conzelmann et al., 1993; Meulenberg et al., 1993a; Meng et al., 1994; Mardassi et 
al., 1995). In vitro transcription and translation studies of the PRRSV ORF 5 in 
the absence of microsomal membranes yielded a protein of 20 K; in the presence 
of microsomal membranes transcription and translation of ORF 5 yielded two 
products, of 25 and 17 K, that were thought to be a glycosylated form of the 
protein (25 K) and a nonglycosylated form from which the N-terminal peptide 
sequence had been removed (17 K) (Drew et al., 1995; Mardassi et al., 1995; 
Meulenberg et al., 1995a). 
The GL glycoprotein of EAV, which is the counterpart of the glycoprotein 
E of PRRSV, contains neutralizing epitopes (Deregt et al., 1994; Balasuriya et al., 
1995) and might play a major role in virus cell interaction. Furthermore, EAV 
GL glycoprotein is associated with the M protein (as are the VP-3 and VP-2M 
proteins of LDV) by a disulfide bond outside the viral envelope; rupture of this 
linkage abrogates virus infectivity (De Vries et al., 1995; Faaberg et al., 1995a). 
Similarly, neutralizing antibodies to PRRSV have been produced by inoculating 
pigs with the protein product of ORF 5 (Persch et al., 1995). In contrast, although 
the E and M proteins or PRRSV are linked by disulfide bonds (Mardassi et al., 
1996), treatment of PRRSV with dithiothreitol (DTT) does not reduce virus 
infectivity (personal observation) as observed with LDV (Faaberg et al., 1995) and 
EAV (De Vries et al., 1995), suggesting that disulfide bonds might have no role in 
PRRSV interaction with cellular receptors. 
Recent investigation has revealed that different degrees of glycosylation of 
the VP3 glycoprotein of LDV dictates the neuropathogenidty of the virus 
(Faaberg et al., 1995b). The presence of an extra glycosylation site hinders LDV 
attachment to neuronal cell receptors leading to decreased pathogenidty. Thus, 
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because the E glycoprotein of PRRSV is also differently glycosylated and because 
of the inconsistency in isolating virus and detecting microscopic lesion in the 
brain, it is tempting to speculate that a similar mechanism could determine 
PRRVS pathogenicity. However, because pathogenicity can be determined by 
even a single or a few nucleotide substitutions in the genome, with its 
subsequent effect on the amino acid sequence, the role of the glycoprotein E in 
virus pathogenicity is yet to be determined. Expression of PRRSV ORF 5 from a 
vaccinia virus vector in mammalian cells induced cell death (apoptosis) in vitro, 
suggesting that this protein might play an important role in the disease process 
(Suarez et al., 1996a). 
Other viral structural proteins 
The molecular characterization of LV indicated that ORFs 4, 3 and 2 
encoded for potential virus envelope glycoproteins (Conzelman et al., 1993; 
Meulenberg et al., 1993a), but their identification in infected cell lysates or 
purified virions had been laborious. Recently, by using polyclonal porcine anti-
LV antibodies, anti-peptide sera and monoclonal antibodies, it was demonstrated 
that the products of these genes are indeed part of the virus structure: the ORF 4 
encodes for a 31-35 K N-glycosylated envelope protein, ORF 3 encodes for a 
40-50 K N-glycosylated envelope protein and ORF 2 encodes for a 29 K protein 
(Meulenberg et al., 1995a; Van Nieuwstadt et al., 1996). It has been suggested that 
these proteins are either present at low levels in viral particles or are poorly 
immunogenic. Recently, monoclonal antibodies have been obtained that reacted 
with 2 glycoproteins, of 30-40 and 40-50 K respectively, both present in purified 
virions (Wieckorek-Krohmer et al., 1996). 
Genotypic and phenotypic diversity among PRRSV isolates 
Diversity among PRRSV isolates has been determined by analysis of the 
nucleotide sequence of the 3' end of several U.S. isolates. Such analysis indicated 
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that there are at least two distinct virus genotypes, the European (LV) and the 
North American (Meng et al., 1995b). This finding was later confirmed by 
additional genetic analysis of European isolates (Suarez et al., 1996b). The 
deduced amino add sequence analysis demonstrated that the ORF 7 is the most 
conserved viral gene among North American isolates, with 95 to 100% amino 
acid sequence identity (Meng et al., 1995a) and only 57 to 59% amino acid 
sequence identity with the LV (Meng et al., 1995b; Murtaugh et al.,1995). The 
amino add sequence of the M protein indicated that it is also highly conserved 
among U. S. isolates (up to 100% amino add sequence identity) (Meng et al., 
1995a) and that it is the most conserved protein between U. S. and European 
isolates (78 to 81% amino add sequence identity) (Meng et al., 1994,1995b; 
Murtaugh et al., 1995). The nudeocapsid and membrane protein contain 
epitopes that are common between North American and European isolates 
(Nelson et al., 1993; De Kluijver et al., 1995). This observation deserves further 
investigation because it might have implication for the development of 
monodonal antibodies that recognize all isolates. The amino add sequence 
identity of glycoprotein E varies from 88 to 97% among U. S. isolates (Meng et al., 
1995a), and from 51 to 59% when compared to the European isolate (Meng et al., 
1994,1995b; Murtaugh et al., 1995). Although the glycoprotein E is the least 
conserved protein among several isolates, it contains distinct conserved regioris 
that might be involved in virus neutralization and/or binding to cellular 
receptors. In contrast, the variable region of this protein might allow virus 
escape from neutralizing antibodies, allowing virus persistence and continuous 
shedding following infection. 
Recent experiments demonstrated that the ORFs 2, 3 and 4 of the PRRSV 
genome encode for structural proteins (Meulenberg et al., 1995a; Van Nieuwstadt 
et al., 1996). Amino add sequence analysis indicated that the identity among 7 
U.S. isolates of PRRSV was 91 to 99%, 86 to 98% and 92 to 99% for the proteins 
encoded for by ORFs 2,3 and 4, respectively (Meng et al., 1995b). In addition. 
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comparison of the LV sequence with the U.S. isolate ATCC VR-2332 indicated 
amino add identity of 63% for ORF 2,58% for ORF 3 and 68% for ORF 4 
(Murtaugh et al., 1995). Similar results were obtained comparing the LV with the 
U.S. isolate VR 2385 (Morozov et al., 1995). 
The divergence at the nucleotide and amino acid sequence level might be 
reflected in outbreak of the virus at the field level. An initial investigation using 
polyclonal sera from naturally or experimentally infected animals indicated a 
broad antigenic variation between U. S. and European isolates and a considerable 
variation among U. S. isolates. Accordingly, antisera raised agaii\st the U. S. 
isolate ATCC VR-2332 had no reactivity at all with 4 European isolates, including 
the original LV isolate, whereas antisera raised against LV reacted with 4 
European and 3 U. S. isolates (Wensvoort et al., 1992a). Monoclonal antibodies 
to the nucleocapsid protein were used to demonstrate antigenic diversity 
between North American and European isolates and to determine the presence 
of common epitopes among all North American isolates (Nelson et al., 1993; 
Magar et al., 1995; Yoon et al., 1995a). Similarly, monoclonal antibodies to the M 
protein demonstrated the antigenic variability among North American and/or 
European isolates of PRRSV (Dea et aL, 1996). 
In addition, genomic differences between North American and European 
isolates have been demonstrated by reverse transcription-polymerase chain 
reaction (RT-PCR). Using a pair of primers for the ORF 7, the RT-PCR generated 
product from the North American isolate was 35 bp larger than the fragment 
obtained from the European isolate (as expected from the nucleotide sequence) 
and easily demonstrated by resolving the amplified products by agarose gel 
electrophoresis (Mardassi et al., 1994b). 
Biological features 
One of the most notable biological features of PRRSV is a restricted cell 
tropism; the LV infects almost exclusively porcine alveolar macrophages (PAM) 
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(Wensvoort et al., 1991, 1992b), and the U.S. isolate infects macrophages and a 
few established cell lines. This feature has prevented isolation and 
characterization of the virus from initial outbreaks of PRES. The U. S. prototype 
isolate VR 2332 replicates in the cell lines CRL 2621 (Collins et al., 1992), MARC-
145 (Kim et al., 1993) and the U. S. isolate VR 2385 replicates in CRL 11171 (Meng 
et al., 1994). In addition, some field isolates do not replicate in these cells. In 
vitro, infection of PAM might be enhanced by the presence of anti-PRRSV 
antibodies (Choi et al., 1992; Yoon, 1996), which could have implications for viral 
pathogenicity. A recent report indicated that porcine peripheral blood monocytes 
were susceptible to PRRSV replication and could be useful for diagnostic 
purposes (Chung et al., 1995). Although most cell lines tested are refractive to 
PRRSV replication, the early events of virus infection of cells, which comprise 
virus binding, interrialization and uncoating, have not yet been investigated for 
PRRSV or any of the other members of the arterivirus group. 
It is assumed that the events following PRRSV entry and uncoating are 
similar to those of other positive-sense RNA viruses, such as coronaviruses, for 
example, to which they are distantly related. Thus, translation of the PRRSV 
RNA polymerase gene would be the first step after imcoating, followed by 
replication of the viral genome and production of mRNA molectiles. 
Concomitantly with the production of viral transcripts, viral encoded proteins 
are synthesized. Viral infection of cells in the presence of inhibitors of DNA 
replication and fluorescent antibody staining of infected cells demonstrated that 
viral replication does not require cellular DNA synthesis and that nascent viral 
antigen is located exclusively in the cell cytoplasm (Benfield et al., 1992) and can 
be detected as soon as 6 hr post infection (p.i.) (Pol and Wagenaar, 1995). Figure 2 
demonstrates the immunofluorescent pattern obtained from staining MARC-145 
cells infected with PRRSV ATCC 2332, using sera from a convalescent pig. Using 
gene specific antisera to the proteins encoded by ORFs 5,6 and 7 and IFA staining 
of cells, Mardassi et al. (1996) demonstrated the intracellular location of the 
Figiire 2. Indirect fluorescent antibody staining of MARC-145 mock infected 
(A) or infected (B) with PRRSV ATCC 2332. Cells were fixed at 24 hr 
p.i. and incubated with anti-PRRSV sera from a pig experimentally 
infected with PRRSV. The second antibody was goat anti-porcine 
immunoglobulin, digested with papain and labelled with fluorescein. 
Notice the cytoplasmic pattern of fluorescence. 
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major viral proteins dtiring virus infection of cells. Accordingly, the E and M 
proteins, encoded by ORFs 5 and 6, respectively, accumulate in the perinuclear 
area, whereas the N protein is foimd throughout in the cell cytoplasm. 
The process of virus assembly has not yet been thoroughly investigated. 
However, limited information has been obtained by electron microscopy. 
Infected cells contain virus particles within tubules and in the lumen of the 
endoplasmic reticulum, and virus budding can be observed from the iimer 
membrane of the endoplasm reticulum (Pol and Wagenaar, 1991; Kuwahara et 
al., 1994; Mardassi et al., 1994a). Aggregations of virus particles in cytoplasmic 
vesicles are usually observed (Fig. 3 (A)). Virus release or egress from infected 
cells might occur by exocytosis (Pol and Wagenaar, 1995), a process that initiates 
at approximately 10 to 12 hr p.i. or by cell lysis, which occurs later during 
infection. Virions can be purified from the supernatant of infected cells by 
centrifugation through cesium chloride gradients (Fig. 3 (B)). The virus growth 
curve, determined by detecting infectious virus in the supernatant of infected 
cells, may vary according to each isolate. Virus infectivity peaks 24 to 48 hr p.i., 
and might be maintained up to 60 hr p.i. (Meng et al., 1996a; personal 
observation). The c)^opathic effect (CPE) caused by PRRSV has been described as 
"rounded clumps of cells, which become pyknotic and detached from the 
monolayer 2-4 days post-inoculation (p.i.)" (Benfield et al., 1992). The entire 
monolayer is eventually destroyed by 6 days p.i. 
Notable in vivo biological features of PRRSV infection are the ability of 
the virus to cause transplacental infection, persist and be shed from infected 
animal (Done et al., 1996) even in the presence of circulating antibodies. 
Antibody-dependent enhancement (ADE) of infection, as observed in vitro (Choi 
et al., 1992) has also been observed in vivo by infecting fetuses in the absence or 
presence of anti-PRRSV antibodies (Christianson et al., 1993a). Thus, because 
fetuses at late gestation are able to mount an humoral immtme response, ADE 
could be one of the explanations for the increased pathogenicity of PRRSV 
Figure 3. (A) Electron micrograph of section of PRRSV-infected MARC-145 
cells prepared at 24 hr p.i. PRRSV accumulation in intracellular 
vesicles is demonstrated. (B) Negative staiiung of partially purified 
virus particles obtained from cesiimi chloride gradient fractions 
of 1.16 - 1.18 g/ml. Bar represents 100 run. 
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during late gestation. In addition, because the porcine matemo-fetal barrier 
becomes more intimate at late gestation, it could favor transplacental infection 
during this period. These viral properties have implication on the vertical and 
horizontal transmission of the virus (see epidemiology and pathogenesis). 
Infected boars intermittently shed viruses in the semen, which can be infectious 
to susceptible females (Yager et al., 1993; Swenson et al., 1994a, 1994b; Christopher-
Hennings et al., 1995a). 
Epidemiology 
Following the initial outbreaks of PRRS in the midwest of the U. S., the 
virus spread rapidly and soon outbreaks of PRRS were reported in a variety of 
U. S. states, Canada, Germany, The Netherlands, United Kingdom, Spain and 
Japan (Goyal, 1993; Meredith, 1993). Although the North American (PRRSV) 
and European (LV) prototype viruses are genotypically distinct (Meng et al., 
1995b), it is unlikely that these two viruses would emerge and evolve almost 
simultaneously in the swine population. Thus, somehow the virus emerged 
and gained worldwide distribution, and, because of PRRSV promiscuous RNA 
replicase protein, genotypically distinct viruses might be detected, which might 
have been evolving through intragenic recombination and random mutations 
of the genome (Kapur et al., 1996). Currently, the virus or the disease has been 
reported in several coimtries around the world (Meredith, 1993). A recent 
serologic survey in swine farms from 18 states of the U. S. indicated that up to 
83% of the farms have been exposed to the virus (Bautista et al., 1993). In 
addition, 70.8% of the positive farms were positive for both the LV and the U. S. 
isolate VR 2332. Although both viruses might be circulating in U.S. farms, it is 
also possible that cross-reactivity between these viruses is responsible for this 
observation. Retrospective serologic studies demonstrated the presence of anti-
PRRSV antibodies in serum samples collected from pigs in the 1980s (Owen et 
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al., 1992). Molecular epidemiology information obtained from nucleotide 
sequence and the rate of synonymous nucleotide substitution indicated that 
PRRSV might have been present in the swine population from 6 to 14 years, 
with an average of nine years of evolution (Kapur et al., 1996), supporting the 
serologic surveillance data of retrospective studies, clinical observations and 
reports of disease outbreaks (Keffaber, 1989). 
Although PRRSV seems to spread quite rapidly, few studies have been 
designed to determine the exact mechanism of PRRSV transmission- Virus 
viability is rapidly lost in most farm fomites, except for water (Pirtle and Beran, 
1996). Thus, direct pig-to-pig contact appears to be the principal method of 
transnnission (Terpstra et al., 1992). Some reports indicated that virus spread 
mostly by aerosols (Keffaber, 1989; Robertson, 1992; Blaha, 1995). Following 
introduction of new animals into a herd, they either bring the virus into the 
herd or they are infected with an already existing virus; high humidity, low 
temperatures and low wind speed appear to facilitate spread of aerosolized virus 
within the herd (Ahl et al., 1992). The virus can persist in some animals for 
weeks or even months after initial infection (Christianson et al., 1992a; Keffaber 
et al., 1992; Terpstra et al., 1992; Zimmermann et al., 1992). Viral transmission 
from infected pigs to contact, naive pigs seems to occur more often during the 
acute phase of infection (Yoon et al., 1993). However, one study determined that 
the source of infection to contact animals was an asjnnptomatic sow that had 
been experimentally infected with PRRSV three months earlier (Zimmermann 
et al., 1992). More recently, virus persistence was determined by isolating the 
virus from serum samples and alveolar macrophages and oropharyngeal swabs 
for several weeks following experimental infection of pigs (Mengeling et al., 
1995; Wills, et al., 1995a; Mengeling et al., 1996b). The effect of corticosteroids on 
re-excretion of PRRSV from infected pigs is controversial, but was observed in at 
least one study (Albina et al., 1994). However, other investigators found that 
corticosteroids had no effect on virus re-excretion (Tersptra et al., 1992; Swenson 
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et al., 1996c). Thus, infected pigs are a major source of virus transmission to 
naive pigs in that they shed the virus in the absence of clinical signs of infection. 
Infectious virus has also been detected in the urine of infected pigs, indicating 
that pig slurry could be a source of infection (Rossow et al., 1994; Wills et al., 
1995b). The time elapsed between introduction of infected animals into the herd 
and the appearance of clinical signs in the contact arumals varies greatly: it can be 
as short as 2 days for gnotobiotic piglets (Wensvoort et al., 1992), up to 28 days for 
pregnant sows (Gordon, 1992) or more than 3 months for adult pigs 
(Zimmermarm et al., 1992). Currently, there is no evidence whether this lag 
time is age-related or is affected by prior infection with a different strain of the 
same virus. 
The virus was isolated from feces of mallard ducks and guinea fowl that 
were given virus in the drinking water, indicating that some avian species could 
spread the virus or be a major reservoir for PRRSV (Zimmermarm et al., 1995). 
In addition, feces from PRRSV-infected mallard ducks were able to cause 
infection in a second group of birds, which in turn propagated the virus and 
served as the source of infection to a third group of mallard ducks 
(Zimmermarm. et al., 1995). Nonetheless, two other avian species tested were 
resistant to virus infection. Mice and rats, which can be foimd in many pig 
operations and are considered as potential carriers of many pathogeruc 
microorganisms, are resistant to infection by PRRSV (Hooper et al., 1994). 
The semen of asymptomatic infected boars has been considered an 
important factor in the transmission of PRRSV (Robertson, 1992; Yager et al., 
1993; Swenson et al., 1994; Gradil et al., 1996). Recent studies demonstrated that 
the semen from infected animals can induce anti-PRRSV antibodies in 
seronegative pigs following intraperitoneal inoculation, indicating that 
infectious viruses present in the semen (Swenson et al., 1994). This test, 
designated biological or "swine bioassay," detected virus in semen for up to 35 
days following experimental infection. In another study, using the polymerase 
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chain reaction (PCR), investigators demonstrated the presence of the virus in the 
semen of naturally and experimentally infected animals (Suarez et al., 1994; Van 
Woensel et al., 1994; Christopher-Heimings et al., 1995b). In addition, the virus 
has been isolated from the genital tract of boars killed 2 weeks after infection 
(Wensvoort et al., 1992). Boars vaccinated intramuscularly with a modified-live 
virus vaccine shed the vaccine virus for up to several months following 
vaccination (Christopher-Herinings et al., 1995a). In addition, when vaccinated 
boars were subsequently challenged with virulent PRRSV, it was foimd that 
vaccination did not prevent seminal shedding of challenge virus. Similar 
results have been reported by Swenson et al (1995a) using an inactivated PRRSV 
vaccine and by Nielsen et al., (1995) using a live-attenuated virus vaccine. 
Conflicting results have been obtained when virus-containing semen was 
deposited by artificial insemination (Al) in the uterus of females with 
synchronized estrous cycle. In one study, it was possible to isolate virus from 
tonsils, lungs and ovaries following Al with contaminated semen (Swenson et 
al., 1995b). Similarly, several gilts bec<ime infected following deposition of virus 
in the uterus shortly after natural service (Lager et al., 1996). In contrast, no 
seroconversion occurred and no virus isolation was possible from six animals 
following Al with semen collected from infected boars (Teuffert et al., 1995). In 
all studies, however, the presence of the virus in the semen and/or following 
intrauterine infection had no significant effect on the rate of conception and 
early pregnancy. Microinjection of PRRSV into swine embryos (4 to 16 cells 
stage) or cocultivation of embryos with PRRSV had no effect on the in vitro 
development of the embryos (Prieto et al., 1996c). Furthermore, the presence of 
virus antigen or nucleic acid could not be demonstrated in association with these 
embryos, suggesting that the embryos were not susceptible to infection (Prieto et 
al., 1996c). 
Although the role of semen as a vehicle for virus transmission is unclear, 
there is evidence that the semen might allow virus spread to naturally served or 
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artificially inseminated females, but it seems that the presence of the virus in the 
semen does not affect the rate of conception. However, because of the limited 
experimental data and the contrasting results already obtained, more 
investigation is required to determine the significance of virus contaminated 
semen in outbreaks and in the dissemination of PRRSV. 
Qinical signs of infection 
Initially, a variety of clinical signs were described in association with 
outbreaks of PRRS. However, with the isolation of the PRRSV and experimental 
reproduction of the disease, certain clinical signs have been more consistently 
observed following PRRSV infection of arumals. The clinical signs of PRRSV 
infection might vary in intensity and severity according to the age of the affected 
animals, genetic susceptibility, environmental/management factors (air quality, 
animal density and movement, housing system), immime status of affected 
animals, the virus strain, or a combination of these factors (reviewed by Done et 
al., 1996). Subcliiucal infections have also been reported and might occur 
frequently (Gordon et al., 1992; Robertson, 1992; Morrison et al., 1992). 
The systemic signs of PRRSV infection include fever, lethargy, cyanosis of 
the extremities, temporary patchy dermal cyanosis, anorexia, agalactia and 
eventually death, mainly in the acute phase of infection (Ahl et al., 1992; Done et 
al., 1996). Labored breathing, coughing and sneezing are the most common 
respiratory clinical observations; systemic and respiratory signs of infections 
"progressively move through a herd giving an appearance of a 'roUing 
inappetence' over several days" (Done et al., 1996). 
The reproductive form of the disease in the female is most commonly 
manifested as early farrowing or late term abortion; normal piglets or weak, 
stillborn, miurunified or decomposing piglets can be found in the same litter 
(Done et al., 1996). The relationship between virus and female infertility is not 
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yet clear. Several reports indicated that affected females had delayed return to 
oestrus and/or persistent rebreeding (Keffaber, 1989; Gordon, 1992; Hooper et al., 
1992). In the boars, PRRSV causes, besides the systemic and respiratory 
symptoms described above, a diminished libido and decreased semen volume 
but no changes in semen quality (Yager et al., 1993; Shin et al., 1995). In contrast, 
following PBJRSV infection of boars, Prieto et al. (1996b) observed spermatozoal 
cells with decreased motility and increased number of spermatozoa cells with 
distal cytoplasmic droplets, and abnormal acrosome structure. 
Congenitally infected piglets and piglets that become infected soon after 
birth are usually unthrifty and may die before weariing (Keffaber, 1989). PRRSV 
infection also causes respiratory distress, "splay legs", abnormal bleeding from 
the riavel or abrasions, skin changes, diarrhea, dehydration, meningitis and 
septicemia (Done et al., 1996). 
Pathogenesis 
The first evidence that an infectious agent was involved with outbreaks of 
PRRS came from studies in which gnotobiotic piglets were inoculated with a 
filtered or imfiltered homogenate of tissues derived from herds experimenting 
outbreaks of PRRS and suspecting to contain a pathogenic microorganism 
(Collins et al., 1990). In this study, the "filterable" nature of the agent was 
determined and the respiratory component of the disease was reproduced 
experimentally. The first clinical signs following exposure to the virus or contact 
with infected animals varies from 1 to 2 days (Wensvoort et al., 1991; Halbur et 
al., 1996b) for young pigs or 4 to 5 days (Terpstra et al., 1991) for adult animals. 
Virus can be isolated for up to 6 weeks after infection from serum samples 
(Ohlinger et al., 1992) and saliva (Wills et al., 1995) or up to 9 weeks from 
alveolar macrophages (Mengeling et al., 1996b) and 157 days from oropharyngeal 
swabs (Wills et al., 1995b). However, in some cases, naive pigs in contact with 
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mfected pigs fail to became infected (Potter, 1996). This might be explained by 
differences in virus pathogenicity or the presence of subpopulation of animals 
that are more resistant to PRRSV infection (Kristensen, 1995; Dee et al., 1996). 
The ability of the virus to cause transplacental infection was 
demonstrated after intranasal infection of pregnant sows with Lelystad virus 
passaged three times in porcine alveolar macrophage (Terpstra et al., 1991) and 
lung homogenate from a gnotobiotic infected piglet (Christianson et al., 1992a). 
Accordingly, some infected sows had an abnormal gestation period and had a 
high percentage of dead fetuses, and virus was isolated from live-bom pigs and 
stillborn fetuses. In other experiments, when pregnant sows were infected at 
midgestation (45 - 50 days of pregnancy), no virus could be isolated from the 
fetvises from 7 to 21 days following infection (Christianson et al., 1992b), 
indicating that no transplacental infection occurred during this period. 
However, fetuses infected in utero supported viral replication (Christianson et 
al., 1992b; Lager et al., 1995a); in utero infection was enhanced by mixing the 
virus inoculum with serum containing anti-PRRSV antibodies, indicating a 
possible role of Fc receptor in virus pathogenesis (Christianson et al., 1992b). 
These experiments indicated that the placenta of midgestation sows was the 
major barrier to fetal infection and that the consequences of viral infection was 
more severe in older fetuses. Furthermore, it was demonsfrated that 
fransplacental infection was more likely to occur when the pregnant female was 
exposed to PRRSV later in gestation (after 90 days) rather than an earlier 
exposure (before 72 days ) (Mengeling et al., 1994). Indeed, the rate of 
transplacental infection and embryo infection at early gestation (7 to 21 days of 
gestation) was approximately 18 and 3%, respectively, in one study (Prieto et al., 
1996a). However, because of the virus ability to persist in the infected animal, a 
midgestation infection might have similar outcome as an infection towards the 
end of the pregnancy. Currently, there is no ii\formation on the mechanism of 
transplacental infection. However, because the virus can be isolated from 
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peripheral white blcx)d cells of infected sows (Wensvoort et al., 1991), it was 
hypothesized that the virus might be carried across the placenta by infected 
macrophages (Pol et al., 1991; Terpstra et al., 1991). In addition, because the 
matemo-fetal blood barrier in the placenta decreases toward the end of gestation, 
transplacental infection is more likely to occur in this period. Transplacental 
infection, as determined by detecting virus in the fetus, might also reflect the 
ability of the conceptus, at different times of gestation, to support virus 
replication, rather than or in addition to the ability of the virus to cross the 
placenta (Mengeling et al., 1994; Lager et al., 1995a). 
Recently, it has been demonstrated that there is a marked difference on the 
pathogenesis of PRRSV strains in pregnant females (Mengeling et al., 1996c). 
Moreover, a single field isolate of PRRSV may comprise a genotypically mixed 
population of virus. A small plaque variant of a field isolate was found less 
pathogenic to pregnant sows than either a large plaque variant or the wild type 
field isolate (Park et al., 1996). 
In a recent study using the U.S. isolate of PRRSV (ATCC VR 2332), no 
correlation was found between pathogenicity and age of infected animals 
(Rossow et al., 1992,1994). Differences in pathogenicity are more likely related to 
individual isolates of the virus; comparative studies on the pathogenesis of 
different U.S. isolates of PRRSV indicated that the severity of the disease, and 
consequentiy of the clinical signs, depends on the virus strain (Halbur et al., 
1996b). This study identified 2 virus groups of low and high virulence, which 
caused mild or severe respiratory infection, respectively, in caesarian-delivered 
colostrvim-deprived (CDCD) pigs. It has been hypothesized that destruction of 
the antigen presenting cells (APCs) might be the major cause of respiratory 
problems (Halbur et al., 1996a) and could therefore predispose the animal to 
secondary infection. 
Because an increased number of secondary bacterial infections have been 
observed in pigs seropositive to PRRSV (Loula, 1991), it has been suggested that 
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PRRSV causes immunosuppression. In one experiment using secondary specific 
pathogen-free (sSPF) piglets, infection by PRRSV followed by infection with 
Streptococcus suis type 2 caused meningitis, whereas animals infected with 
PRRSV or S. suis alone had no clinical signs or lesions of central nervous system 
infection (Galina et al., 1994). Infection of pigs with PRRSV seems to increase the 
probability of infection by Mycoplasma hyorhinis, but not of M. hyopneumoniae 
of M. hyosynovia (Kobayashi et al., 1996). In contrast, other reports indicated that 
there is only mild or no interaction between PRRSV and either 
M. hyopneumoniae (Albina et al., 1995; Van Alstine et al., 1996a), Pasteurella 
multocida (Carvalho et al., 1995), Haemophilus parasuis (Solano et al., 1995) and 
Actinobacillus pleuropneumoniae or influenza virus (Pol et al., 1995), or with 
Haemophilus parasuis, Streptococcus suis, Salmonella choleraesuis and 
P. multocida (Cooper et al., 1995). In fact, previous infection by PRRSV appeared 
to improve the immune response to pseudorabies virus (PRV) vaccination and 
subsequent challenge with virulent PRV (Albina et al., 1995). Dual infection of 
10-week-old pigs with PRRSV followed by infection with porcine respiratory 
coronavirus (PRCV) or swine influenza virus (SIV) induced prolonged fever and 
increased weight loss in the piglets compared to single infection by each of the 
viruses; however, prior infection by PRRSV did not affect the rate of excretion of 
PRCV and induced a relative delay on the excretion of SIV (Van Reeth et al., 
1996). Although some reports indicate a synergistic interaction between PRRSV 
and other microorganisms, there are still conflicting results incriminating 
PRRSV as a triggering agent for other respiratory diseases (Zeman, 1996). 
Lesions 
Marrnscnpic lesions 
The severity of lesions found following PRRSV infection might be related 
to the virus strain. Done et al., (1992) reported that the only alteration observed 
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in uncomplicated field cases of PRRSV in Great Britain was the presence of clear 
fluid in the thoracic cavity. Similarly, following experimental infection of piglets 
with the U. 5. isolate VR 2332, no gross lesions were observed, except for small 
abscesses in the retropharyngeal tissue (Collins et al., 1992). In contrast, Lelystad 
virus induced "pneumonic areas in the front lobes, edema in the peritoneal and 
perirenal fat, mesenteric lymph nodes and subcutaneous fat and muscles" (Pol et 
al., 1991) 
Recently, however, using several U.S. isolates of PRRSV, the pathological 
changes following infection by PRRSV were characterized in gnotobiotic pig. 
Accordingly, macroscopic lesion of uncomplicated PRRSV infection, when 
present, are usually confined to the lungs and lymph nodes; the affected area of 
the lungs range from approximately 10 to 70% of consolidation, depending on 
the virus strain involved (Halbiir et al., 1996). Pneumonic areas are most 
commonly observed in the apical, middle and accessory lobes and eventually in 
the ventromedial region of the caudal lobes (Halbur et al., 1996). These areas are 
tan-gray colored, fail to collapse and have a firm parenchyma (Pol et al., 1991; 
Halbur et al., 1996). PRRSV-induced limg lesions are usually multifocal and less 
frequently lobular in nature; regional lymph nodes are usually enlarged, swollen 
and tan colored (Halbur et al., 1996). 
In the pregnant uterus, besides dead and mummified fetuses, PRRSV 
infection can cause detachment of fetal from maternal placenta; the fetal placenta 
might be "brownish-green discolored and with a greasy consistency" (Stockhofe-
Zurwieden et al., 1993). The umbilical cord of the fetus might be distended with 
hemorrhagic areas ranging from 1-2 cm to the complete length of the cord (Lager 
and Halbur, 1996). 
Microscopic lesions 
Similarly to macroscopic lesions, the microscopic lesions following 
PRRSV infections are more prominent in the lungs and lymph nodes. 
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Frequently, however, microscopic lesions are also observed in the nasal 
turbinates, tonsils, heart, brain, kidneys and spleen of infected animals (Pol et al., 
1991; Collins et al., 1992; Halbur et al., 1996a, 1996b). In the lungs, the hallmark of 
PRRSV infection is a prominent, multifocal histiocytic interstitial pneumonia 
characterized by thickening of the alveolar septa due to mononuclear cell 
infiltration. Hypertrophy and hyperplasia of t)^e 2 pneumocytes and the 
presence of exudate on the alveoli space, which contains macrophages, cell debris 
and multinucleated cells is also observed (Pol et al., 1991; Collins et al., 1992; 
Halbur et al., 1996). Bronchiolar and bronchial epithelia are usually not affected. 
Microscopically, infected lymph nodes are hyperplasic and contain single 
or multiple foci areas of germinal center necrosis (Collins et al,, 1992; Halbur et 
al., 1996). These areas are characterized by pyknotic lymphocyte nuclei and 
karyorrhectic debris. Follicles may contain blast of lymphocytes and tangible 
body macrophages (Collins et al., 1992; Halbur et al., 1996). The perifollicular area 
might also become involved. 
Nasal mucosa of infected animals may contain mild to moderate 
multifocal lymphohistiocytic rhinitis, with loss of cilia, swelling and vacuolation 
of turbinate epithelium and clear spaces containing small amounts of cell debris 
(Pol et al., 1991). The nasal turbinate lamina propria can contain a 
lymphoplasmatic cell population- The submucosa may be edematous and 
suppurative inflammation can be observed (Pol et al., 1991). 
Microscopic lesions in the myocardium are characterized by multifocal 
histiocytic and lymphoplasmacytic inflammation most commonly observed 
around the vessels (Collins et al., 1992). 
Microscopically, encephalitis caused by PRRSV infection is characterized 
by perivascular cuffing of mononuclear cells with few eosinophils and mild to 
moderate gliosis (Collins et al., 1992; Halbur et al., 1996). Similar lesions can be 
also observed with less frequency in the medulla, choroid plexus and cerebellum. 
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An early study on the pathogenesis of LV demonstrated that the virxis 
induced microscopic alteration in the liver, spleen and thymus. In the spleen, 
the lesions were characterized by depletion of lymphocytes from the 
periarteriolar lymphocytes sheets and degenerated ellipsoids with karyorrhexis 
and vacuolization (Pol et al., 1991). Liver lesions were dwacterized by single cell 
necrosis and dilated sinuses containing neutrophils. The thymic cortex was 
depleted of lymphocytes. 
A recent investigation on PRRSV antigen distribution following infection 
of young pigs indicated the presence of viral antigen in the lungs, heart, lymph 
nodes, tonsils, thymus, spleen, intestine, kidneys, liver and adrenal glands 
(Halbur et al., 1996a). The cells containing PRRSV antigen in these organs where 
those of the macrophage/monocyte/dendritic lineage. 
Uterine lesions consist of endometritis, placentitis and "multifocal 
separation of the materna-fetal contact area" (Stockhofe-Zurwieden et al., 1993; 
Lager and Halbur, 1996); a multifocal inflammatory cell infiltration consisting 
mainly of lymphocytes and macrophages was observed in the lamina propria of 
the endometrium, in the perivascular connective tissue and in the vascular wall. 
Electron microscopy observation of these samples identified virus-like particles 
in the luminal cytoplasmic membranes (Stockhofe-Zurwieden et al., 1993). 
Fetal lesions following natural or experimental infection have been 
recently described (Lager and Ackerman, 1994; Lager and Halbur, 1996; Rossow et 
al., 1996). Lesion can be observed in the heart, lung, brain, vascular endothelium 
and umbilical cord. The heart may contain generalized lesions with areas of 
myofiber loss and replacement by fibrous connective tissue, and interstitial fod 
of lymphocytes and plasma cells (Rossow et aL, 1996). Perivascular cuffing of 
lymphocytes and plasma cells may be observed in the cerebellar white matter 
(Lager et al., 1994; Rossow et al., 1996). Vascular lesions in specific organs are 
characterized by endothelium necrosis. Arteries can be surrounded by 
lymphocytes and maaophages, which can also be foimd within the tunica media 
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and subendothelial layer (Lager and Ackerman, 1994; Lager and Halbur, 1996; 
Rossow et al., 1996). Cross-sectioning of the umbilical cord might reveal 
extensive hemorrhage into the connective tissue surrounding the vein and 
artery, which may contain necrotizing and fibrinosuppurative arteritis; 
segmental necrotizing areas of the ttmica intima and media of the cord artery 
may be present, and the tunica adventitia can be hemorrhagic (Lager and Halbur, 
1996). The lesions in the lungs of aborted fetuses are characteristic of interstitial 
pneumonia as described above for young piglets. 
Immunology 
The antibody response to the viral major structural proteins has been 
discussed above. Usually, the humoral response develops from 7 to 10 days p.i. 
and can be detected by indirect fluorescent antibody staining of infected cells. 
Currently, there is ample evidence that infection by PRRSV induces protective 
immunity. Lager et al., (1995a) reported that gilts exposed to PRRSV isolate 
NADC-8 at the time of breeding (day zero) were protected from homologous 
challenge but only partially protected from heterologous challenge at day 90 of 
gestation. Repeated reproductive failure is not observed in herds persistently 
infected with PRRSV (Done et al., 1996). Vaccination of animals in endemic 
areas might prevent occurrence of reproductive failure (Kritas et al., 1995; Plana 
Duran et al., 1995) but not the onset of respiratory problems. No reproductive 
failure has been found in gilts that have seroconverted before insemination 
(Leyk et al., 1995). Although the results are conflicting, vaccination of boars 
seems to reduce shedding of vaccine or challenge virus in the semen, indicating 
some level of protection (Shin et al., 1995; Swenson et al., 1996a). 
Piglets nursing immune sows seem to be protected from infection but 
become infected when colostral antibodies decay (Albina et al., 1994). Virus can 
be isolated from infected animals several weeks or even months following 
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infection, when serum antibodies have already been detected. However, there is 
evidence that virus replication can be enhanced in the presence of circulating 
antibodies (Yoon et al., 1996). In fact, antibody enhancement of infection has 
been demonstrated in vitro using porcine alveolar macrophages (Choi et al.,1992) 
and in vivo by infecting fetuses in the presence or absence of antibodies 
(Christianson et al., 1992b). Nonetheless, virus neutralization can be 
demonstrated in vitro by using continuous cell lines (Benfield et al., 1992; Frey et 
al., 1992; Morrison et al., 1992). Adding 20% of normal fresh swine senmi to the 
diluent increase the sensitivity of the serum-neutralization test (Yoon et al., 
1994). PRRSV neutralizing antibodies have been detected in pigs inoculated with 
baculovirus-expressed glycoprotein E (ORF 5) (Persch et al., 1995). Inunimization 
of piglets with baculovirus-expressed product of PRRSV ORF 3 alone induced 
higher protection that immunization with glycoprotein E alone; highest level of 
protection was found by immunization with the product of ORF 3 in association 
with glycoprotein E (Plana Duran et al., 1995b). 
The role of immune cells on PRRSV infection has been poorly 
investigated. The alveolar macrophages are thought to be the main cell target for 
virus replication (Pol et al., 1991). Following infection, virus antigen is almost 
exclusively detected in antigen presenting cells (APCs) of several organs (Halbur 
et al., 1996a). Alveolar lavage from non-infected piglets yield 95% macrophages 
in the total number of cells, in contrast to 50% in PRRSV-infected animals 
(Molitor et al., 1992; Zhou et al., 1992). This proportion raises to 80% at 27 days 
p.i. Thus, there is a marked reduction of the number of alveolar macrophages 
during PRRSV infection of piglets, which has major consequences on defense 
mechanisms and susceptibility to secondary infections. In addition, there is a 
temporary reduction on the number of T lymphocytes and a significant 
leucopenia and thrombocytopenia (Christianson et al., 1992a). 
Using a lymphocyte proliferation and delayed type hypersensitivity (DTH) 
assays, Bautista et al., (1995) determined that infected pigs developed a PRRSV 
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antigen specific cell-mediated immime (CMI) response that could be blocked by 
anti-CD4 and anti-MHC class II antibodies. The proliferation response was 
detected from 4 to 11 weeks p.i. Pigs naturally infected with PRRSV have 
increased number of CD2+ and CD8+ cells and decreased CD4+ cells and 
CD4+/CD8+ ratios (Shimizu et al., 1996). Infection of SPF piglets induced a 
decrease in total Ijonphocytes and in the CD2+ and CD4+ cell coimt by day 3 p.i.; 
Although CD4+ cells remained low for at least 14 days, CD8+ cells were found 
decreased in number by day 3 only and were slightiy higher from day 28 to 35 p.i. 
In the same study, PRRSV was not considered cytotoxic for CD4+ cells or 
mitogenic for CD8+ cells. The significance of these findings has yet to be 
investigated; it is evident, however that there is an urgent need to investigate 
the role of CMI in PRRSV infection. 
Diagnosis 
Porcine reproductive and respiratory syndrome virus should be 
considered as a cause in outbreaks of respiratory distress in pigs of all ages. The 
involvement of PRRSV becomes even more suspicious when the herd is 
simultaneously affected with reproductive problems, as for example, early 
farrowing/late term abortion and a sudden increase in the number of 
mimimified fetuses and stillbirths. At necropsy, few gross lesions are observed 
and, when present, are confined to the lungs (consolidation) and enlargement of 
lymph nodes (Pol et al., 1991; Collins et al., 1992; Halbur et al., 1996). Microscopic 
lesions characteristic of PRRSV infection are interstitial pneumonia with 
thickening of the alveolar septa. Tissue samples recommended for 
histopathology are lungs, brain, heart, lymph nodes, spleen and riasal turbinates 
(Pol et al., 1991; Collins et al., 1992; Halbur et al., 1996). 
The presence of anti-PRRSV antibodies in fetal fluids or in blood collected 
from stillborn and weak piglets before colostrum ingestion is an indication of 
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PRRSV infection. Similarly, a 4-fold rise in the anti-PRRSV antibody titer of sera 
collected during outbreaks and 3 to 4 weeks later indicates an active infection. 
Antibodies to PRRSV proteins have been detected by indirect fluorescent 
antibody (IFA) (Yoon et al., 1992a), serum neutralization (SN) (Benfield et al., 
1992; Frey et al., 1992; Yoon et al., 1994), immunoperoxidase monolayer assay 
(IPMA) (Wensvoort et al., 1992), enzyme-linked immimosorbent assay (ELISA) 
(Albina et al., 1992; Choi et al., 1996) and blocking ELISA (Houben et al., 1995). 
Seroconversion to PRRSV might be detected by IPMA as early as 5 days p.i. and 
by IFA, ELISA and WB as soon as 7 days p.i. (Yoon et al., 1995; Houben et al., 
1995). Earlier detection of infection is also possible using IFA that detects 
antibodies of the IgM class, as recently reported (Park et al., 1995). Neutralizing 
antibodies usually appear after a few weeks following infection and are better 
detected by using 20% of normal swine sera in the antibody dilution media 
(Yoon et al., 1994). Recent findings demonstrated that the early anti-PRRSV 
antibodies are mainly directed to the N and M protein, as determined by western 
blot (Nelson et al., 1994; Yoon et al,, 1995b). Usually, antibodies to the E 
glycoprotein appear late during infection (after 4 weeks). Contrasting results 
have been obtained by Loemba et al., (1996) who detected antibodies to the 
envelope glycoprotein E at 7 days p.i., followed by detection of antibodies to the 
N and M proteins by the end of the second week p.i. Theoretically, based on a 
constant rate of antibody decay, antibodies to PRRSV might still be detected by 
IFA at 137 days p.i. (Yoon et al., 1995b). In addition, it has been demonstrated that 
the ELISA test performance is similar to the IFA or DPMA test and that the ELISA 
is more efficient in detecting antibodies early during infection (Nodelik et al., 
1996; Yoon et al., 1995b). 
The implication of PRRSV with outbreaks of PRRS requires the isolation 
of the virus from recently infected or diseased animals. Isolation of infectious 
virus can be attempted from a variety of tissues; viruses might be isolated from 
bone marrow, thymus, spleen, heart, brain, liver, kidneys, tonsils and lymph 
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nodes of adult animals or stillborn fetuses (Goyal, 1993; Done et al., 1996). Serum 
samples are very useful and convenient for virus isolation (Van Alstine et al., 
1993; Mengeling et al., 1995a). Samples collected for virus isolation should be 
refrigerated or frozen (Van Alstine et al., 1993,1996b). Recently, a simple 
procedure has been devised that allows collection of PAM from live animal, or at 
necropsy, that can be used for virus isolation by culturing the PAM in vitro or to 
demonsfrate the presence of virus antigens by EFA (Mengeling et al., 1995b, 
1996b). Those studies indicated that PAMs were more reliable for virus isolation 
than any other tissue or even sera samples. Because some isolates replicate 
poorly in cells in culture, immunostaining of cells used for virus isolation might 
be required if CPE is not apparent following virus inoculation to the cells. 
The presence of virus in tissue homogenates or serum can also be 
demonstrated by using the RT-PCR (Mardassi et al., 1994c; Suarez et al., 1994; 
Van Woensel et al., 1994 ), which can be as sensitive as virus isolation in cell 
culture. In fact, the RT-PCR is the technique of choice to determine the presence 
of PRRSV in semen samples (VanWoensel et al., 1994; Christopher-Hennings et 
al., 1995b, 1996) mainly because of the cytotoxic components of semen. Although 
a PCR-based diagnostic method is relatively expensive and might not be 
recommended for routine use, it might have application to detect possible 
contamination of semen intended to be widely distributed. In addition, PCR-
based diagnostic has the potential to differentiate infection by different isolates of 
the virus, as for example between European and North American isolates 
(Mardassi et al.,1994b). 
Virus antigens might be detected in formalin-fixed tissue samples that 
have been used for histopathology; several immunohistochemical methods 
have been developed to detect PRRSV antigens in infected tissues (Magar et al., 
1993; Halbur et al., 1994; Larochelle et al., 1994; Larochelle and Magar, 1995; 
Sur et al., 1996). In addition, in situ hybridization might be used to detect nucleic 
acid of viral origin in these samples (Larochelle et al., 1996; Sur et al., 1996). In 
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fact, in a comparative study of two histochemical diagnostic procedures, Sur et al 
(1996) found that samples collected at later times p.i., but not during the acute 
phase of infection, contained more cells expressing PRRSV RNA than did cells 
containing PRRSV antigen. In addition, these investigators provided evidence 
that type pneumocytes II might be involved in virus replication. These 
techniques have been useful for diagnostic purposes, for the retrospective study 
of PRRSV infection and to elucidate the pathogenesis of PRRSV infection. 
Porcine reproductive and respiratory syndrome virus can be isolated in 
PAMs (Wensvoort et al., 1991), MARC-145 cells (Kim et al., 1993), CRL 2621 cells 
(Collins et al., 1992) and CRL 11171 (Meng et al, 1994,1996). However, PAMs 
appear to be more reliable that other cells for virus isolation, mainly because 
many field isolates of PRRSV are not able to replicated in continuous cell lines 
(Bautista et al., 1992) and because PAMs contain receptors for the Fc region of 
immunoglobulins (Fc receptors) that might enhance virus attachment to the 
cells and the possibility of virus isolation from serum samples. 
A differential diagnosis of PRRS outbreaks should consider infection by 
porcine parvovirus, pseudorabies virus, hemagglutinating encephalomyelitis 
virus, porcine enterovirus, swine influenza virus, hog cholera virus (in endemic 
areas), porcine cytomegalovirus and leptospiroses (Leptospira pomona and L. 
bratislava) (Keffaber, 1989). 
Treatment, control and prevention 
Similar to many other viral infections of animals, there is no known 
therapeutic drugs to specifically treat PRRSV infection. However, antibiotic 
therapy should be used to prevent secondary infection by bacteria and 
mycoplasma (Keffaber, 1989). 
Because pig-to-pig contact might be the most important method of virus 
transmission and because the virus can persist in the presence of neutralizing 
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antibodies and the absence of clinical signs of infection (Goyal et al., 1993; Done et 
al., 1996), introduction of new animals into the herd should follow strict testing 
and quarantine procedures. Other precautions include restriction of visitors to 
the animal facilities, cleaning trucks used for animal transport, changing boots 
and clothes after handling animals, and restraining the access of wild birds to the 
operation (Goyal et al., 1993). Several other management practices have been 
reported to control spread of virus within and between herd; "...measures that 
have been recommended by the European Community during an acute outbreak 
are: 1) breed extra sows and maintain extra gilts, 2) dispose of placentas, fetuses 
and dead piglets from all abortions and premature farrowing properly because 
they may contain large quantities of virus in lungs, blood and other organs, 
3) farrowing quarters should be cleaned thoroughly after abortion and premature 
farrowing, 4) entrances and exits of the breeding house should be disinfected and 
movements of breeding pigs to noninfected holdings should be stopped and 
5) all transport vehicles must be thoroughly sealed and disinfected" (Goyal, 1993). 
New practices, as nurse depopulation (ND), have been introduced to swine 
producers (Dee and Joo, 1995). Accordingly, ND in association with cleaning and 
disinfection, allowed improvement in postweaning growth rate and decrease in 
mortality. Other management practices recommend "all in - all out" for all 
production stages and the elimination of weak or moribund animals and 
Cross fostering animals only during the first 24 hr of age (McCaw and 
Henry, 1995). 
During low incidence of PRRS and limited spreading of the virus, 
practices such as slaughtering all positive animals might be considered (Le Potier 
et al., 1995), followed by control of animal movement and the use of AI. 
Whenever AI is used, the semen should be tested for the presence of the virus by 
using the RT-PCR. 
Few studies have been conducted to determine the levels of protection 
provided by vaccination or previous infection. One study determined that an 
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U.S. strain provided 100% immunological protection to pregnant gilts against 
challenge to homologous virus but only partial protection to challenge with an 
European strain (Lager et al., 1995). Prophylactic vaccination of sows seems to be 
effective in preventing the reproductive component of the syndrome, such as 
mummified and stillborn fetuses and weak bom piglets (Gorcyca et al., 1995; 
Plana Duran et al., 1995a) but appears to be ineffective in preventing respiratory 
problems in growers and finisher pigs (Kritas et al., 1995). Additionally, in 
similar studies, no virus could be isolated from semen of vaccinated boars, 
indicating some level of protection (Shin et al., 1995). Thus, vaccination of 
breeding animals seems to be an effective measure to prevent at least the 
outcome or reproductive problems. However, because only partial protection is 
conferred by heterologous infections and the vaccine virus can cause 
transplacental infection (Lager et al., 1995; Mengeling et al., 1996c), it would be 
preferable to avoid PRRSV infection of the breeding herd until a "universal" 
PRRSV vaccine becomes available. 
Neutralizing epitopes have been identified in association with the protein 
product of ORF 5 (the E glycoprotein) (Persch et al., 1995). In contrast, vaccination 
of pregimnt sows with recombinant proteins obtained from ORF 3, 5 or 7 
followed by challenge with virulent virus indicated that the gene product of ORF 
3 and 5 conferred up to 63% and 45.5% of protection (% of live piglets after 40 
days), in comparison to 9.6% of piglets survival in nonvacdnated animals (Plana 
Duran et al., 1995b). Thus, this study indicated the involvement of the protein 
product of ORF 3 in inducing immune protection. However, because of the 
variability of the virus RNA genome and because the exact role of each protein 
in virus structure is not yet clear, more information is needed to define the viral 
components inducing immime protection. 
Recently, it has been indicated that the parental type of major 
histocompatibility complex (MHC) class I possibly influence the survival of the 
offspring following infection with PRRSV (Kristensen, 1995), and some 
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subpopulation of animals are more resistance to infection (Dee et al., 1996). 
Thus, it seems that the outcome of infection is a balance between pathogenicity 
of different isolates and yet unknown host related factors. 
Virus-cell interaction: a general view 
Virus interaction with cells has been generally classified in a sequence of 
distinct steps: binding or attachment, entry or penetration, uncoating of the viral 
nucleic acid, genome expression and replication, assembly of virus particles and 
exit from the infected cell. 
Investigation of the initial stages of virus-host cell interaction, that is, 
binding to cellular receptors, entry and uncoating, has been mostly 
overshadowed by other more attractive aspects of the virus molecular biology, 
such as replication and gene expressioa However, in recent years, the cell 
tropism, binding and entry mechanism of a variety of virus has been 
determined. For some viruses, the significance of these events has yet to be 
determined. However, for viruses as the human immtmodefidency virus 
(HIV), the narrow cell tropism pointed towards a receptor molecule unique in 
the permissive cells that would allow virus binding and entry. Indeed, enfry of 
HIV into cells depends on the presence of the CD4 molecule (Maddon et al., 
1986), which is the hallmark of a specific subset of cells from the immune system; 
in addition, a second, recently identified receptor molecule also plays a critical 
role in virus infection of cells (Alkhatib et al., 1996; Deng et al., 1996; Dragic et al., 
1996; Feng et al., 1996). Currently, great efforts are directed towards 
understanding the regulation of these receptor molecules in an attempt to 
prevent HIV from binding to, and entering, permissive cells. 
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Virus binding 
The first step of virus infection of cells is binding to specific cellular 
components. Binding is mediated by a virus attachment protein (VAP) and 
receptors on the target cell usually designated as "viral receptor" (Lonberg-Holm, 
1981; Marsh and Helenius, 1989). Virus binding to cellular receptors depends on 
several factors such as temperature, pH and composition of the media, ionic 
strength, and the presence of serum in the media (Lonberg-Holm, 1981). Because 
viruses and cells are constituted by several identical molecules, binding occurs 
through multivalent interaction between virus and cells. Binding is thought to 
occur by random contact between virus and cells, until a specific receptor is 
"found". Following the irutial contact, other VAPs interact with their cognate 
molecules on the cell surface, leading to strong interaction that allows virus to 
enter the cells (Lonberg-Holm, 1981). The strength of VAP and receptor 
interaction is variable and might be related to the number of receptors on the cell 
surface. 
However, the presence of a receptor per se is not sufficient to assure virus 
binding, entry and replication. Several other factors might restrict virus 
infection of cells at different stages of the replication cycle, such as virus 
internalization, uncoating, gene expression and replication, and virus assembly. 
Thus, because all intracellular events related to virus infection occur 
subsequently to virus-cell receptor interaction, the expression of viral receptors 
on target cells might be considered a major determinant of cell tropism, virus 
replication and pathogenesis. 
Generally, virus binding studies have been conducted by using 
radioactively labelled purified virus. To prevent virus internalization, which is 
the next step, viruses are incubated with cells at 4°C or in the presence of drugs 
that inhibit virus uptake. Following extensive washing, cell-associated 
radioactivity is determined. However, alternative methods to determine virus 
binding are being used more frequently, such as fluorescein- and biotin-labeled 
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virus, and the determination of non-labeled virus that binds to cells and might 
be recovered in an infectious form. 
Virus binding to receptors on the cell surface might involve the 
participation of intermediate molecules that mediate the interaction between the 
VAP and cell surface receptors. Anti-viral antibodies, in many instances, have 
been recognized as the intermediate molecules that enhance virus binding and 
ii\fection to cells displaying a receptor for the Fc region of the antibody molecule 
(Halstead, 1994). 
Virus entry 
Following binding to specific cellular receptors, enveloped viruses enter 
the cells by either one of two mechanisms; a) by direct fusion of the viral 
envelope with the cytoplasmic membrane, at neutral pH, or b) by receptor-
mediated endocytosis followed by a low pH-induced fusion of the viral envelope 
with the membrane of the corresponding vesicle; thus, according to the 
mechanism of entry, enveloped viruses have been classified into pH-
independent and pH-dependent viruses (Marsh and Pelchen-Matthews, 1994). 
Initial investigations on the mechanism of virus entry were based on 
morphological observation of virus/cell interaction; controversial data indicated 
that viruses could become associated with endocytic vesicles (Marsh and Pelchen-
Matthews, 1994). However, pioneer work by Helenius et al., (1982) demonstrated 
that lysosomotropic agents (weak bases and carboxylic ionophores, see below), 
which neutralize acidic vesicles (Poole and Ohkuma, 1981) were able to inhibit 
Semliki forest virus (SFV) infection of cells indicating that the endocytic 
mechanis was used for virus entry. These compounds have since been used to 
determine the mechanism of entry for a variety of viruses (Table 1). Thus, it is 
assumed that a virus belongs to the pH-dependent group and enters cells by 
receptor-mediated endocytosis, when infection of cells by this virus is ir\hibited 
by lysosomotropic agents. In contrast, virus infection of cells in the presence of 
47 
Table 1. Addic-dependence of cell entry by virusesa. 
Mechanism Virus Virus Group 
pH-dependent 
Sindbis virus, SFV alphavirus 
influenza A, B, C orthomyxovirus 
West riile virus flavivirus 
VSV, rabies virus rhab do virus 
La Crosse virus bunyavirus 
MMTV retrovirus 
African swine fever virus iridovirus 
rhinovirus, FMDV picornavirus 
adenovirus type 2 adenovirus 
reovirus type 3 reovirus 
canine parvovirus parvovirus 
pH-independent 
Newcastle disease virus paramyxovirus 
Rous sarcoma virus retrovirus 
HIV-l, 2, SIV refrovirus (lenti) 
herpes simplex virus herpesvirus 
SV40, polyomavirus papovavirus 
porcine rotavirus rotavirus 
duck hepatitis virus hepadna virus 
hepatitis A picorna 
a modified from Marsh and Pelchen-Matthews, 1994. Abbreviations are: 
SFV, Semliki forest virus; VSV, vesicular stomatitis virus; MMTV, mouse 
mammary timior virus; FMDV, foot-and-mouth disease virus; PIEV, human 
immunodeficiency virus; SIV, simian immunodeficiency virus. 
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these drugs suggests that the virus enters by a pH-independent mechanism, such 
as fusion with the cytoplasmic membrane. 
Entry of pH-independent group of viruses 
The exact mechanism of entry of the pH-independent group of viruses is 
still controversial. Because pH-independent viruses infect cells in the presence 
of weak bases and carboxylic ionophores and consequently do not require a low 
pH to enter the cells, it has been assumed that fusion of viral envelope with cells 
at the cytoplasmic membrane translocates the virus to the interior of the cell 
(Marsh and Helenius, 1989). Indeed, morphological studies have demonstrated 
that herpes simplex virus type 1 (HSV-1, Fuller and Spear, 1987) and HIV (Stein 
et al., 1987) for example, can penetrate and infect cells by fusion at the cell surface. 
However, the same viruses also have been observed inside endocytic vesicles, 
suggesting that the fusion event might also occur from within endocytic vesicles 
(Campadelli-Fiume et al., 1988; Bauer et al., 1987). If so, resistance to inhibition 
by lysosomotropic agents is not an absolute indication that fusion occurred at the 
cell surface. 
The fusion event of the pH-independent viruses is thought to be triggered 
by specialized viral encoded proteins, which, upon binding to the cellular 
receptors, undergo structural rearrangements, exposing domain(s) that mediate 
fusion of the viral envelope with the cytoplasmic membrane at the cell surface 
and entry at neutral pH (Marsh and Helenius, 1989). In contrast, molecules on 
the target cell other that the binding receptor might be required to promote 
fusion. In the case of HIV, the Fusin molecule (Feng et al., 1996) and the 
CC-CKR5, a b-chemokine receptor (Alkhatib et al., 1996; Deng et al., 1996; Dragic 
et al., 1996) have been foimd to interact with the HIV attachment protein, the 
envelope glycoprotein (gpl20), allowing cell-bound virus to enter the cells by 
direct fusion. 
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Entry of the pH-dependent group of viruses 
Several enveloped viruses depend on a low pH to trigger the fusogenic 
activity of viral encoded proteins and to gain access to intracellular 
compartments (Marsh and Pelchen-Matthews, 1994). Intracellular vesicles, as 
endosomes, contain the adequate conditions (i.e., low pH) required to trigger 
fusion (Marsh and Pelchen-Matthews, 1994; Gaudin et al., 1995). In this case, 
following virus binding to appropriate receptors, these viruses are internalized 
within cellular vesicles that eventually mature to endosomes (March and 
Helenius, 1989), which, in turn, are acidified by the vacuolar type of proton-
ATPase (Mellman et al., 1986; Nelson and Taiz, 1989). In addition to receptor 
binding, the low endosomal pH contributes to change the conformation of the 
viral attachment protein, triggering its fusogenic activity (Gaudin et al., 1995). It 
is assumed that a virus enters cells by receptor-mediated endocytosis when 
infection of cells by this virus is inhibited in the presence of weak bases and 
carboxylic ionophores. Weak bases (ammonium chloride, chloroquine and 
amantadine) cross membranes in the unprotonated form and accumulate inside 
acidic vesicles, neutralizing the pH; carboxylic ionophores (nigericin and 
monensin) raise the vesicular pH by exchanging H+ by Na+ or K+ (Ohkuma and 
Poole, 1978; Maxfield, 1982). In addition, more recentiy, a specific irihibitor of the 
vacuolar type of proton-ATPase, Bafilomydn Al (Bowman et al., 1988; Hanada et 
al., 1990; Drose et al., 1993; Rautiala et al., 1993), has been used to determine the 
requirement of a low pH during the initial stages of virus infection of cells (Perez 
and Carrasco, 1994; Guinea and Carrasco, 1995). 
Classical examples of pH-dependent viruses are the SFV, VSV, and 
influenza A virus. Infection of cells by SFV is inhibited by weak bases and 
carboxylic ionophores (Miller and Lenard, 1981; Helenius et al., 1982; Marsh et al., 
1982; Talbot and Vance, 1982). Internalization of SFV was shown to occurs by 
receptor-mediated endocytosis, in clathrin-coated vesicles, wherein a low pH was 
required to trigger fusion (Helenius et al., 1980, Marsh and Helenius, 1980; Marsh 
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et al., 1983; Doxsey et al., 1987). The internalization mechanism of VSV and 
influenza A virus is similar to SFV in that infection occur from intracellular 
vesicles and is inhibited by lysosomotropic agents (see Matlin et al., 1982b; 
Supperti et al., 1987 for VSV and Matlin et al., 1982a; Yoshimura et al., 1982; 
Shibata et al., 1983 for influenza A virus). 
Because endocytosis is observed only in viable cells, using the endocytic 
pathway to enter the cells ensures that pH-dependent viruses will encounter an 
environment wherein fusion can occur and the genome can be delivered to an 
intracellular compartment that supports replication. However, regardless of the 
entry mechanism, the viral nucleocapsid and/or the viral genome is delivered to 
the interior of the cell wherein events related to gene expression and genome 
replication initiate. Freeing of the viral genome from the nucleocapsid of 
enveloped viruses is a process virtually unexplored. Studies involving SFV 
indicated that cellular components, like the 28 S RNA of the large ribosomal 
subimit, play a major role in disassembling viral nucleocapsid released into the 
cytoplasm (Singh and Helenius, 1992a). In contrast, influenza virus imcoating is 
mediated by viral encoded proteins. The M2 protein of influenza virus, an ion 
channel protein that is activated by low pH, mediates the influx of protons into 
the viral core leading to nucleocapsid dissociation in the cytoplasm (Singh and 
Helenius, 1992b; Greber et al., 1994). 
As discussed above, inhibition of virus replication (as measured by virus 
yield) by these drugs suggests that receptor-mediated endocytosis followed by a 
low pH is required for virus entry. However, because some of these drugs also 
affect other cellular functions (Tartakoff, 1983; Mellman et al., 1986) and might 
interfere with later steps of virus replication, an early event of virus replication, 
such as uncoating or genome replication, in addition to virus yield, should be 
measured to ascertain their effect upon virus entry. In addition, their effect on 
virus replication should be negligible when added after virus uncoating (usually 
1 hr after addition of virus to cells). Alternatively, electron micrographs of virus 
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and cell interaction provide physical evidence of the mechanism of virus entry 
in that virus particles might be observed fusing at the cell membrane or entering 
cells by endocytosis. Thus, the combination of lysosomotropic drugs and electron 
microscopy are usually used to determine the pathway of virus entry. 
Although the initial events of virus infection of cells occurs almost 
simultaneously, binding, entry and uncoating are considered distinct steps of the 
infection cycle, which is then followed by gene expression, replication, assembly 
and exit from the infected cell. Virus binding per se is not an indication of 
permissibility to infection. Binding may or may not be followed by entry, which 
in turn may or may not be followed by uncoating. There are several instances in 
which the sole expression of a viral receptor is not sufficient to allow virus entry 
and replication. As mentioned above, HIV infection of cells depends on the CD4 
molecule and a secondary cellular component (Alkhatib et al., 1996; Deng et al., 
1996; Dragic et al., 1996; Feng et al., 1996); similarly, infection of cells by viruses 
such as mouse hepatitis virus (Asanaka and Lai, 1993; Yokomori et al., 1993), 
human adenoviruses (Wickham et al., 1993), herpes simplex virus (Kaner et al., 
1990), pestiviruses (Flores et al., 1996) and others require the presence of several 
cellular components that are critical for entry or uncoating of the virus. 
Statement of the Problem 
Porcine reproductive and respiratory syndrome is a relatively new disease 
of swine that has had a great impact on the swine industry and constitutes a 
major threat to swine producers. Isolation of the virus in cells in culture, which 
allowed its subsequent characterization, was reported only several years 
following the initial outbreaks of the syndrome, and after tenuous testing of 
several primary and continuous cell types. Currently, few established cell lines 
have been found to support PRRSV replication, and there are isolates that still 
require cultures of porcine macrophages for in vitro propagatiori. Basically, 
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there is no information concerning the initial stages of PRRSV infection of cells. 
My hypothesis is that resistance of cells to PRRSV replication occurs during the 
initial stages of virus infection of cells and that binding to cells is a complex 
mechaixism that is mediated by one or more viral structural proteins. 
Consequently, the experimental work reported here was designed to investigate 
some of these aspects of PRRSV replication in cells. The major aims were: 
1) investigation of the mechanism(s) that restrict PRRSV replication in. cells in 
culture. 2) determine the mechanism by which PRRSV enters susceptible cells, 
and 3) characterize the major structural proteins of the virus and their role in 
virus-cell interaction. 
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CHAPTER 3. PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME 
VIRUS ENTERS CELLS THROUGH A LOW PH-DEPENDENT 
ENDOCYTIC PATHWAY 
A paper published in Virus Research (volume 42, pages 137-147,1996) 
Luiz C. Kreutz and Mark R. Ackermann 
Abstract 
The entry pathway of porcine reproductive and respiratory syndrome 
virus (PRRSV) into MARC-145 cells was investigated using a variety of drugs 
that interfere with the pH of intracellular vesicles by different mechanisms. 
Virus entry was assessed by measuring viral RNA replication or production of 
infectious virus. Chloroquine, ammoniimi chloride and bafilomycin A1 
inhibited RNA replication or production of infectious virus in a dose-dependent 
manner. These drugs inhibited virus replication when added to the cells prior to, 
at infection or soon after ii\fection. Moreover, the effect of chloroquine on 
PRRSV replication was reversible under acidic conditions of the media. Taken 
together, these results indicated that a low pH was required during virus entry. 
Electron microscopic data showed virus particles at the cell surface or within 
small vesicles which were circimiscribed by a clathrin-like zone. In addition, the 
nimiber of PRRSV-ir\fected cells was decreased in the presence of cytochalasin B 
and phenylarsine oxide. Thus, we concluded that PRRSV entry might occur 
through a microfilament-dependent endocytic mechanism in which a low pH is 
necessary for proper virus uncoating. 
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1. Introduction 
Porcine reproductive and respiratory syndrome virus (PRRSV) was 
recently isolated, characterized and included into a newly proposed family of 
viruses, tentatively named Arteriviridae (Wensvoort et al., 1991; Conzelmarm et 
al., 1993; Meulenberg et al., 1993). Other members of this family are the lactate 
dehydrogenase-elevating virus (LDV) of mice, the equine arteritis virus (EAV) 
and the simian hemorrhagic fever virus (SHFV: Plageman and Moening, 1992). 
The PRRSV contains a positive-sense, non-segmented, polyadenylated RNA 
genome of approximately 15 Kb (Conzelmarm et al., 1993; Meulenberg et al., 
1993). Three major viral structural proteins have already been identified; a 
glycosylated envelope (E) protein, a transmembrane (M) protein and the 
nucleocapsid (N) protein (Meuleriberg et al., 1995; Drew et al., 1995). None of 
these proteins has yet been associated with receptor binding or neutralizing 
epitopes. However, the major envelope glycoprotein of EAV, the GL 
glycoprotein, contains neutralizing epitopes, implicating a possible role in virus 
attachment and entry (Deregt et al., 1994; Balasuriya et al., 1995; Chirnside et al., 
1995). In addition, the transmembrane and envelope protein of LDV and EAV 
form disulfide-linked heterodimers that are essential for virus infectivity 
(Faaberg et aL, 1995; De Vries et al., 1995). Because the cystine motifs of these 
proteins are conserved among arteriviruses, it might be speculated that this 
observation applies to the other members of these family, and that they share a 
similar mechanism of virus-cell interaction. 
Because no information concerning the interaction of arteriviruses with 
cells in culture and the mecharusms that restrict virus replication in most cells 
are available, we investigated the mechanism of PRRSV entry into cells. The 
pathway of virus penetration has been determined for many viruses. Following 
binding to specific receptors on the cell surface, some enveloped viruses might 
enter cells by direct fusion of their envelope with the cell membrane, at neutral 
pH (Marsh and Heleruus, 1989). Other enveloped viruses require a low pH to 
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trigger the fusogenic mechanism (Gaudin et al., 1995) which usually occurs in the 
endosome. The entry of the pH-dependent group of viruses can be prevented by 
drugs that irthibit endosome acidification. Weak bases (diloroquine and 
ammonium chloride), carboxylic ionophores (monensin and nigericin), which 
prevent endosome acidification by different medianisms (Maxfield, 1982; 
Ohkimia and Poole, 1978), and bafilomycin Al (Baf Al), which inhibits the 
enzyme responsible for endosome acidification (Bowman et al., 1988; Drose et al., 
1993; Hanada et al., 1990; Rautiala et al., 1993), have been used to demonstrate the 
requirement of a low pH during the initial stages of cell infection by a variety of 
viruses. In this report we demonstrate that these drugs inhibit an initial stage of 
PRRSV replication, indicating that PRRSV enters cells through an endocytic 
mechanism in which an acidic pH is required for a productive infection. 
2. Materials and methods 
2.1. Virus and cells 
The U. S. isolate of porcine reproductive and respiratory syndrome virus 
(PRRSV) ATCC VR-2332 (Benfield et al., 1992; Collins et al., 1992) was plaque 
purified and used in these experiments. MARC-145 cells were maintained in F-15 
miiumal essential media (MEM) supplemented with 5% fetal calf serum. Virus 
stock was produced by infecting MARC-145 cells with PRRSV at a multiplicity of 
infection (m.o.i) of 1 CCID50 (cell culture infectious dose that causes cytophatic 
effect in 50% of the inoculated wells)/cell. Infected cell supematants were 
collected at 24 hr post infection (p.i.), clarified by centrifugation (10000 x g), and 
the virus titer determined in MARC-145 cells grown in 96 well plates. In 
addition, PRRSV was ptirified through cesium chloride gradient as described 
elsewhere (Meng et al. 1994). Porcine alveolar macrophages (PAM) were collected 
from 2-month-old pigs by lung lavage, and seeded on 6-well plates and 
maintained with MEM supplemented with 10% calf senmi. 
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2.2. Chemical compounds 
All drugs were purchased from Sigma chemical company (St Louis, MN). 
Stock solutions of chloroquine, ammonium chloride and amantadine were 
prepared in water, at concentrations of 50 mM, IM and 20 mM respectively. 
Monensin, nigericin, and cytochalasin B were diluted in ethanol at 
concentrations of 1 mM, 100 ^iM, and 5 mM, respectively. Phenylarsine oxide 
and bafilomycin A1 were prepared in dimethyl sulfoxide (DMSO) at 
concentrations of 50 mM and 100 |iM respectively. Appropriate amounts of each 
drug were added to cell culture media to achieve the required concentration as 
stated in the figure legends. Cell viability was measured by trypan blue exclusion 
in cells grown for 24 hr under the highest drug concentration, and was greater 
than 90%. 
2.3. Effect of drugs on PRRSV replication 
MARC-145 cells grown in 6-well plates were infected with PRRSV at a 
m.o.i of 10 CCIDso, in the presence or absence of chloroquine and ammonium 
chloride, and incubated at 37°C for 1 hr. The virus inoculum was removed and 
the cells washed 3 times with MEM containing the appropriate drug 
concentration. The cells were then incubated in the presence or absence of the 
drugs. Cell supernatant was harvested at 24 hr p.i., centrifuged briefly to remove 
floating cells and stored at -70®C prior to titration. Virus titer in the supernatant 
was determined 4 days after inoculation of MARC-145 cells grown in 96-weil 
plates. Porcine alveolar macrophages were seeded in 6-well plates and processed 
similarly. The effect of Baf Al, cytochalasin B and phenylarsine oxide on PRRSV 
replication was determined by indirect fluorescent antibody staining of the cells. 
Cells grown in 4-well chambers were infected at an m.o.i. of 0.1 CCID/so in the 
presence or absence of the drugs, washed and incubated for 14 hr. Then, the 
supernatant was removed and the cells fixed and immimostained with a porcine 
anti-PRRSV polyclonal antibody, followed by a FTTC-conjugated goat anti-
porcine immunoglobulin (Mengeling et al., 1995). In addition, the effect of 
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chloroqiiine and Baf A1 was investigated by detecting viral RNA at 10 hr p.i., in 
cells iiifected during treatment with these drugs. Total cellular RNA was 
extracted from mock-infected or PRRSV infected cells as reported elsewhere 
(Chomczynski and Sacchi, 1987) and slot-blotted to nitrocellulose membranes 
using a 24-well slot-blot apparatus. Alternatively, for the Baf A1 study, infected 
cells were blotted to nitrocellulose (Paeratakul et al., 1988). Viral specific RNA 
was detected using a RT-PCR generated cDNA probe labelled by a 
chemiluminescence system (ECL, Amersham,IL), following manufacturer's 
instruction. The RT-PCR primers were based on the sequence of isolate VR 2385 
(Meng et al., 1994) and encompassed ORF 7 of the viral genome. Cycling 
conditions and primers sequences will be published elsewhere (manuscript in 
preparation). 
2.4. Electron microscopy during PRRSV infection of cells 
Confluent monolayers of MARC-145 cells in 4-well chambers were cooled 
to 4° for 30 min. Cesium chloride concentrated PRRSV was then added at a m.o.i 
of approximately 1 x 103 CQDso/cell and incubated in MEM. After 1 hr at 4°C, 
the monolayers were washed 3 times with cold MEM. One set of cells were fixed 
and the remaining were incubated with pre-warmed medium at 37°C for up to 
10 minutes. The cells were then fixed with glutaraldehyde, removed from the 
chamber and processed for electron microscopy by standard procedures. For 
immunogold labelling, the grids were treated for 20 min with a saturated 
solution of sodiimi metaperiodate and rinsed 10 times in distilled water. The 
grid was dried in a filter paper and blocked in PBS contairung 2% bovine serum 
albumin (BSA) for 1 hr at 37°C. The grids were then incubated with a porcine 
anti-PRRSV polyclonal antibody in PBS 0.1% BSA for 16 hr at 4°C. After washing 
with 25 mi of PBS 0.1 % BSA, the grids were incubated for 1 hr at 37°C with a 
droplet containing 1:10 dilution of protein A-gold (10 nm, Sigma). 
The grids were washed, stained with lead citrate and uranyl acetate and observed 
with a transmission electron microscope. 
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3. Results 
3.1. Lysosomotropic drugs inhibit an early step of PRRSV replication 
The requirement for a low pH during initial stages of PRRSV interaction 
with MARC-145 cells and PAM in culture was initially investigated by 
examining the effect of increasing concentrations of chloroquine on the virus 
yield from chloroquine treated infected cells. Preliminary experiments 
demonstrated that PRRSV-infected cells had detectable levels of nascent viral 
RNA approximately 8 hr p.i., and started releasing virus into the supernatant at 
approximately 14 to 16 hr pi. (data not shown). In these experiments all 
measurements were performed to measure primarily infected cells: we collected 
infected cells for RNA assay at 10 hr p.i., or immunostained at 14 hr p.i., and the 
supernatant was collected before or at 24 hr. p.i. to assure that only virus yield 
from primarily infected, but not from reinfected cells was measured. 
Monolayers of MARC-145 cells or PAM were treated with different 
concentrations of chloroquine from 30 min prior to infection to 24 hr p.i., and 
the virus yield was quantitated in the supernatant of infected cells. The results 
obtained (Fig. la) demonstrated that chloroquine effectively inhibited virus 
production by MARC-145 cells and macrophages in a dose-dependent fashion. 
In the absence of chloroquine, the yield of PRRSV after 24 hr of infection was 
7.4 X 107 CCIDso/ml (data not shown). Subsequently, the effect of chloroquine 
was assessed by measuring nascent viral RNA in infected cells. The production 
of viral RNA in MARC-145 cells infected and treated under the same conditions 
(Fig. lb) was substantially reduced by chloroquine. Taken together, these results 
indicated that chloroquine blocks a step of virus replication prior to synthesis of 
viral RNA. 
To further determine at which point virus replication was inhibited by 
lysosomotropic drugs, we performed a series of experiments in which 
chloroquine and ammonium chloride were added prior to, at infection, or at 
different times p.i. When added prior to infection or at infection, chloroquine 
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(20 nM) and ammonium diloride (5 mM) greatly reduced the production of 
infectious virus (Fig. Ic). However, when the drugs were added 30 min or later 
after viral infection, no significant inhibition of virus production was observed. 
This clearly indicated that RNA replication per se (Fig. lb) was not inhibited by 
chloroquine, but a step prior to RNA replication, e.g. virus entry was blocked. 
Subsequently, the effect of Baf A1 on virus entry was investigated by 
immunostaining infected treated cells (Fig. 2a). As indicated, Baf A1 at 
concentrations of 0.1 nM reduced infection of cells by 40%, whereas at 1 
concentration, Baf A1 completely blocked PRRSV infection of cells, indicating 
the requirement of proton-ATPase activity during virus replication. Bafilomycin 
A1 had a greater effect when added at infection or soon after infection (Fig. 2b) 
and inhibited virus replication by 25% when added at 1 hr p.i. Analysis of viral 
RNA from these cells (2c) was consistent with the immunofluorescent studies, 
and further indicated that Baf A1 was interfering with an early stage of virus 
infection. 
The replication of PRRSV was also inhibited by a variety of other drugs 
which interfere with acidification of endosomes in a dose dependent fashion 
(Table 1). Higher concentrations of ammonium chloride or amantadine were 
required to block virus replicatiori. However, these compoimds were less toxic to 
cells than nigericin and monensin as measured by trypan blue exclusion (data 
not shown). The time dependence irUiibitory effect of these drugs was also 
investigated (data not shown). All drugs had pronounced effect when present 
prior to, at infection and shorter thereafter, having little effect when added more 
than 1 hr p.i., except moner\sin and rugericin, which decreased virus 
replication by approximately 60% when added as late as 8 hr p.i. 
3.2. The inhibitory effect of chloroquine on PRRSV replication is reversible 
under acidic conditions of the media 
In another experiment, the requirement of an acidic pH during virus entry 
was demonstrated by reversing the effect of chloroquine in virus-infected ceUs. 
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Monolayers of MARC-145 cells were infected in the presence of chloroquine 
(20 nM) and virus was allowed to adsorb for 30 min. The inocula was then 
replaced by medium at pH 5.5, 6.5 or 7.5 containing chloroquine and incubated 
for 30 min. In a parallel experiment without chloroquine, the production of 
infectious virus by infected cells was not affected at the pH range 5.5 to 7.5 (Fig 3). 
However, in the presence of chloroquine the production of infectious virus was 
substantially reduced in infected cells exposed to pH 7.5. In contrast, at pH 6.5 the 
effect of chloroquine was less pronounced, and was almost negligible at pH 5.5. 
3.3. PRRSV enter cells through small vesicles 
Following the observation that the virus requires an addic environment 
to enter the cells, we sought to determine the pathway of PRRSV entry. 
Monolayers of MARC-145 cells grown on 4-well chambers were infected with a 
m.o.i. of approximately 1 x 103 CCIDso/per cell at 4°C. After 1 hr, the temperature 
was shifted to 37°C and the cells fixed at different times p.i. and observed by 
electron microscopy. At time zero, PRRSV particles were seen at the cell surface 
(Fig. 4a and 4b). After 2 min at 37°C, virus particles were observed within small 
vesicles circumscribed by a clathrin-like zone (Fig. 4c and 4d). The identity of the 
virions at the cell sujrface was determined by immunogold staining of infected 
cells using a porcine anti-PRRSV serimi and protein A gold-conjugated (Fig. 4e 
and 4f). No virus particles were detected fusing at the plasma membrane, 
indicating that receptor mediated endocytosis is involved in this process. 
3.4. Cellular microfilaments are involved in PRRSV entry 
After demonstrating that PRRSV enters cells through small vesicles, we 
examined the role of cellular microfilaments during PRRSV entry by using 
cytochalasin B and phenylarsine oxide. MARC-145 cells grown in 4-well 
chambers were treated with different concentrations of cytochalasin B and the 
percentage of infected cells was determined at 14 hr p.i. by immunofluorescent 
staining. Small concentrations of cytochalasin effectively reduced virus infection 
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of cells (Fig. 5), indicating that a microfilament-dependent process is involved 
with virus entry. The effect of phenylarsine oxide, a specific inhibitor of 
endocytosis, was investigated under the same conditions. Pretreatment of cells 
with 1 of phenylarsine oxide reduced the infection of cells by greater than 
90% (data not shown). Taken together, these results indicate that the entry of 
PRRSV into MARC-145 cells is a microfilament-dependent process such as 
classical phagocytosis. 
4. Discussion 
During our studies of PRRSV internalization by cells in culture, the effect 
of lysosomotropic drugs on virus uptake was investigated. We used three weak 
bases (chloroquine, ammonium chloride and amantadine), which in the 
unprotonated form cross membranes and accumulate in acidic vesicles, 
neutralizing the pH; two carboxylic ionophores (monensin and nigericin), which 
raise the vesicular pH by substituting by Na+ of K+ (Maxfield, 1982; Ohkuma 
and Poole, 1978); and Baf Al, a novel microlide antibiotic that selectively inhibits 
the vacuolar type of proton-ATPase, the enzyme responsible for endosome 
acidification (Bowman et al., 1988; Drose et al., 1993; Hanada et al., 1990; Rautiala 
etal., 1993). 
Neutralizing the endosomal pH with these drugs impairs imcoating of 
pH-dependent viruses and blocks further replication (Marsh and Helenius, 1989). 
This suggests that the endocytic pathway followed by a pH-dependent step is used 
during virus entry. However, when these drugs are present in the culture media 
during virus replication, they may also interfere with later steps of replication. 
Thus, an early event following virus attachment, such as imcoating or RNA 
replication, should be measured to determine whether lysosomotropic drugs 
inhibit virus entry. In addition, these drugs should have minimal effect on virus 
yield when added after virus uncoating, during the replication process. 
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The lysosomotropic drugs used in these studies inhibit endosome 
acidification by different mecahnisms. They efficiently blocked the replication of 
PRRSV suggesting that acidic conditions of the internalization pathway were 
required for virus replication. Similar observations have been reported for 
influenza virus (Yoshimura et al., 1982; Shibata et al., 1983; Guinea and Carrasco, 
1995), lymphocytic choriomeningitis virus (Borrow and Oldstone, 1994), 
vesicular stomatitis virus (Matlin et al,, 1982; Perez and Carrasco, 1994), semliki 
forest virus (Helenius et al., 1982; Marsh et al., 1983; Palokangas et al., 1994), and 
african swine fever virus (Alcami et al., 1989) which have a well characterized 
mechanism of cell entry. However, because some of these drugs were present in 
the culture media during the complete replication cycle of PRRSV, they could 
have inhibited other steps of virus replication that depend on cellular functions, 
like protein transport and exocytosis, as described previously (Mellman et al., 
1986; Tartakoff, 1983). Thus, to determine that they had effect on early stages of 
virus replication, the production of viral RNA, one of the earliest steps of the 
replication process, was also measured. Chloroquine and Baf Al effectively 
reduced the amount of viral RNA detected at 10 hr p.i., indicating that an early 
event of virus replication was blocked. In addition, chloroquine and 
ammonium chloride mediated their effect when present during the first 30 min 
of the infection cycle, and reduced the production of infectious virus by 
approximately 10% when added subsequentiy. In contrast, the observation that 
the number of infected cells, as measured by immunofluorescent staining, was 
still decreased by approximately 25% when Baf Al was added as late as 1 hr p.i. 
might reflect the different methods used to evaluate the effect of these drugs. 
Nonetheless, these results are consistent with their acting upon virus entry and 
suggest that virus internalization might be an asynchronous process. 
Yoshimura et al. (1982), and Shibata et al. (1983), studying the entry 
mechanism of influenza virus, demonstrated that optimal concentrations of 
chloroquine in cellular endosomes was achieved when the pH of the culture 
media was neutral. In this situation, endosomal pH reached a maximimi of 6.1 
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blocking virus uncoating. In contrast, the effect of chloroquine on virus 
replication could be reversed under acidic conditions of the media, when the 
endosomal pH would drop to physiological values, allowing virus replication. 
Similar to influenza virus, the inhibition of PRRSV replication by chloroquine 
was greatly diminished when the pH of the media was 5.5 during the 
chloroquine-sensitive period. In the absence of chloroquine, the replication of 
PRRSV was not affected at the pH range of 5.5 to 7.5. These data strongly suggest 
that a pH threshold of approximately 6.5, as observed in early endosomes, is 
required during virus entry. 
The role of receptor mediated endocytosis and cellular microfilaments in 
virus entry has been recently discussed (Marsh and Pelchen-Matthews, 1995). 
Although uptake of some viruses occurs through smooth-walled vesicles 
(Borrow and Oldstone, 1994; Miller and Hutt-Fletcher, 1992; Nemerow and 
Cooper, 1984), most enveloped viruses enter the cells through clathrin-coated 
vesicles (Marsh and Pelchen-Matthews, 1995). In these experiments, electron 
microscopy analysis of virus and cell interaction demonstrated that PRRSV 
particles were contained in relatively small vesicles which appeared to be 
clathrin coated, as observed in classical phagocytosis. Kowalchyk and Plagemarm 
(1985), demonstrated that LDV particles were located in similar vesicles during 
the initial stages of macrophages infection. Thus, it appears that receptor 
mediated endocytosis might be a common entry mechaiusm for arteriviruses. 
Endocytosis is a microfilament dependent mechanism that can be inhibited by 
cytochalasin (MacLean-Fletcher and Pollard, 1980) and phenylarsine oxide 
(Gibson et al., 1989). In this regard, PRRSV entry was effectively blocked by these 
compounds indicating that virus internalization is a microfilament-dependent 
mechanism. Similar concentrations of cytochalasin B had no effect on 
LCMV, a virus that enters cells by a microfilament-independent mechanism 
(Borrow and Oldstone, 1994), and much higher concentrations were required to 
block HSV entry, which fuses the viral envelope at the cell membrane (Wittels 
and Spear, 1990; Fuller and Spear, 1987). In addition, during electron microscopy 
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studies of virus and ceil interaction, direct fusion of PRRSV envelope with 
cellular membrane was not observed at any time. Consequently PRRSV entry 
most likely occurs by receptor mediated endocytosis. 
In summary, based on our observations, the mechanism of PRRSV entry, 
which might be common to other members of this family, appears to involve 
binding of virioris to specific, yet unknown receptors on the cell surface. 
Following binding, virus particles are then internalized by a microfilament-
dependent process through small, clathrin-like coated vesicles. During this stage, 
an acidic pH is required to trigger a fusion event between viral envelope and the 
endosomal membrane allowing the viral nucleocapsid to enter the cytoplasm for 
replication. 
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Figure 1. Effect of chloroquine and ammonium chloride on PRRSV replication. 
(A) Monolayers of MARC-145 cells ( -•- ) or porcine alveolar 
macrophages (-o-) grown in 6-well plates were incubated with 
chloroquine at the indicated concentration for 30 min prior to infection 
with PRRSV at a m.o.i. of 10 CCIDso/cell. After 1 hr at 37°C the virus 
inoculum was removed and the cells washed three times with MEM 
with the appropriate drug concentration. Cells were then incubated for 
24 hr in the presence of chloroquine when the supernatant was 
collected for virus titration. Bars represent one standard deviation of 
three separate experiments. The replication of PRRSV was completely 
inhibited in PAM using 40 jiM of chloroquine. (B) RNA slot-blot of 
PRRSV infected MARC-145 cells treated with cWoroquine. Five jig of 
total RNA from infected cells treated with chloroquine as indicated, 
was blotted per well and detected using a chemilimiinescent labelled 
probe comprising the ORF 7 of the viral genome. 
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Figure 1, continued. (C) Effect of time of addition of chloroquine and 
ammonium chloride on their ability to inhibit the production of 
infectious PRRSV. MARC-145 cells grown in 6-well plates were treated 
with chloroquine (20nM) or ammonium chloride (5 mM) prior to, at 
iiifection, or p.i., as indicated. One hour after addition of virias (m.o.i. 
of 10 CCIDso/cell), ceils were washed three times with media 
containing the appropriate drug concentration, and incubated for 24 hr 
at 37°, when supernatant was collected to determine virus yield. Bars 
represent on standard deviation from the mean of three experiments. 
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Figure 2. Effect of bafilomydn A1 on PRRSV infection of cells. 
(A) MARC-145 cells grown in 4-well chambers were infected with 
P^SV at an m.o.i. of 0.1 CCIDso/cell. Bafilomydn A1 was added to 
the cells 15 min prior to infection and was present during adsorption 
and incubation. The cells were fixed at 16 hr pi. and immunostained as 
described in the text. Each experiment was repeated three times and 
five fields were observed in each well (~ 3500 cells/field). The number 
of positive cells in the absence of the drug was considered as 100%. Bars 
represent one standard deviation ftrom the mean. 
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Figure 2, continued. (B) Time dependence action of bafilomydn A1 on PRRSV 
entry. MARC-145 cells were grown, infected and processed for 
fluorescent antibody staining as stated in the legend of figure 2. 
Bafilomydn A1 (0.5 |iM) was added to the cells at the indicated time 
during infection. The number of infected cells is shown as percentage 
of untreated infected cells. Each experiment was replicated three times 
and five fields counted in each well (~3500 cells/field). Bars represent 
one standard deviation firom the mean. C = control. (C) RNA analysis 
of PRRSV infeded cells treated with Baf Al. One pM of bafilomydn A1 
was added to the cells at the indicated time during infection. Cells 
were infeded and processed for RNA detection as described in the text 
C = control, untreated infeded cells. 
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Figure 3. pH-dependence of PRRSV entry. Monolayers of MARC-145 cells 
in 6-well plates were infected with PRRSV at an m.o.i. of 10 
CCIDso/cell in the absence (-o-) or presence (-•- ) of chloroquine. 
After 30 min, the virus inoculum was removed and the cells incubated 
with media (20 mM HEPES) at the indicated pH for 30 min. The media 
was then removed and the cells incubated at pH 7.2. The production of 
infectious virus was measured at 24 hr p.i. 
Figtire 4. Electron microscopy analysis of PRRSV interaction with cells in 
culture. Monolayers of MARC-145 cells grown in 4-well chambers 
were cooled to 4°C prior to infectious witii PRRSV at a m.o.i. of 
1 X 103 CCIDso/cell. One hour after addition of the virus, the cells 
were washed three times with cold media, fixed with glutaraldehyde 
and processed for electron microscopy by standard procedures. 
Another set of cells were warmed to 37®C for up to 10 min and 
processed similarly. Virions can be observed attached to the cell 
surface (a and b) or within small vesicles (c and d). The identity of 
the virus was demonstrated by immunogold labelling (e and f). Bar 
sizes are: A and E = 100 nm; B = 45 nm; C and D = 65 nm; F = 85 nm. 

78 
90-
80-
70-« u 
60-
s 
50-e 
40-
30-
20 0 5 10 15 
Cytochalasin B concentration (uM) 
Figure 5. Effect of cytochalasin B of PRRSV entry. MARC-145 cells grown in 
4-well chambers were treated with cytochalasin B for 1 hr prior to 
infection with PRRSV at an m.o.i. of 0.1 CCIDso/cell. The cells were 
fixed 14 hr p.i. and incubated with porcine anti-PRRSV polyclonal 
antibody followed by a FTTC-conjugated goat anti-porcine antibody. 
Fluorescent cells were counted in 8 fields per well (~3500 cells/field). 
The number of infected cells in the absence of cytochalasin was 
considered as 100%. 
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Table 1. Effect of various agents which interfere with intravesicular pH on 
PRRSV replication, as quantitated by virus yield. 
Treatment Virus Yield (logio CCIDso/ml) 
Amantadine: 
1.0 mM 
0.5 mM 
0.1 mM 
0.05 mM 
0.02 mM 
Control 
2.7 (0.5)a 
3.7 (0.6) 
6.3 (0.7) 
6.7 (0.5) 
6.7 (0.5) 
7.7 (0.5) 
Ammonium Chloride: 
15.0 mM 
5.0 mM 
1.0 mM 
0.5 mM 
0.25 mM 
Control 
Nigericin: 
0.8 uM 
0.4 uM 
0.1 uM 
0.06 uM 
0.02 uM 
Control 
2.5 (1.2) 
2.7 (0.5) 
6.5 (0.4) 
6.7 (0.4) 
7.5 (0.5) 
7.7 (0.5) 
2.7 (0.5) 
4.7 (0.9) 
6.3 (0.6) 
7.5 (0.5) 
7.7 (0.5) 
7.7 (0.5) 
Monensin: 
6.0 uM 
2.0 uM 
0.8 uM 
0.4 uM 
0.1 uM 
Control 
3.5 (0.4) 
4.3 (0.5) 
7.5 (0.5) 
7.5 (0.5) 
7.5 (0.5) 
7.5 (0.5) 
a Number within brackets are standard deviation of the mean of three 
experiments. 
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CHAPTER 4. CELLULAR MEMBRANE FACTORS ARE THE MAJOR 
DETERMINANTS OF PORCINE REPRODUCTIVE AND RESPIRATORY 
SYNDROME VIRUS TROPISM 
A paper to be submitted for publication in Virus Research 
Luiz C. Kreutz 
Abstract 
The mechanism that restricts porcine reproductive and respiratory 
syndrome virus (PRRSV) tissue tropism and replication in a variety of cell lines 
has been investigated in this study. Using a virus binding assay, it was found that 
PRRSV could not bind to several cell lines. Vero cells, which are non-permissive 
to PRRSV infection, were able to bind and internalize virus almost as effidendy 
as the permissive cell line MARC-145. Following treatment of cell-bound virus 
with polyethylene glycol (PEG), infectious virus was recovered from Vero and 
MARC-145, but not from the several other cells tested. Vero cells internalized 
PRRSV in an infectious form, indicating that virus entry occurred by receptor 
mediated endocytosis. Irifectious virus was recovered from a variety of cells 
fransfected with viral RNA, indicating that the viral genome is infectious per se, 
and that the infracellular milieu was permissive to viral replication. Thus, 
absence of PRRSV binding to cells is a major determinant of tissue tropism. 
However, because Vero cells restricted PRRSV replication following virus 
internalization but prior to RNA replication, it was concluded that multiple 
viral and cellular components might be involved in allowing virus binding, 
enfry and uncoating in permissive cells. 
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1. Introduction 
Porcine reproductive and respiratory syndrome virus (PRESV) has been 
identified as the causative agent of a new disease of swine that is characterized by 
reproductive failure of pregnant sows and respiratory distress of unweaned and 
growing pigs (reviewed by Done et al., 1996). Following PRESV isolation and 
partial characterization, the virus has been tentatively classified as an arterivirus 
(Wensvoort et al., 1991; Benfield et al., 1992; Collins et al., 1992; Conzelmann et 
al., 1993; Meulenberg et al., 1993) along with equine arteritis virus (EAV), lactate 
dehydrogenase-elevating virus (LDV) and simian hemorrhagic fever virus 
(SHFV) (Plagemann and Moening, 1992). A notable feature of PRRSV and other 
arteriviruses is their tropism for macrophages and the ability to persist in 
infected aiiimals (Goyal, 1993). 
Porcine reproductive and respiratory syndrome virus contains a lipid 
envelope and a positive serise, non-segmented RNA genome of approximately 
15 BCb, which is polyadenylated at the 3' end (Conzelmann et al., 1993; 
Meulenberg et al., 1993); the genome contains 8 open reading frames (ORFs) that 
are expressed as a nested set of 3' co-terminal subgenomic RNAs. The first ORF 
(ORF la/lb) is thought to encode for the RNA replicase protein; ORFs 2 to 6 
encode for potentially envelope-associated proteins and ORF 7 encodes for a basic 
capsid protein (Conzelmann et al., 1993; Meulenberg et al., 1993). None of these 
proteins has yet been associated with receptor binding and tissue tropism. 
Recently, however, it has been demonstrated that the proteins encoded by ORFs 5 
and 6 (E and M, respectively) occur as disulfide-linked heterodimers in the 
virion surface (Mardassi et al., 1996), similarly to their counterparts in LDV and 
EAV (Faaberg et al., 1995; De Vries et al., 1995). Disruption of the disulfide bonds 
between the envelope and transmembrane proteins of LDV by reducing agents 
abrogates viral infectivity suggesting a major role of these proteins and their 
association for proper virus-receptor interaction (Faaberg et al., 1995). 
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Although PRRSV replication occurs only in a few established cell lines 
(Wensvoort et al., 1991; Benfield et al., 1992; Mardassi et al., 1993; Meng et al., 
1996), the mechanism (s) that restrict PRRSV replication in most cell lines has 
not yet been investigated. Recently, we demoristrated that PRRSV enters 
MARC-145 cells through a mechanism of receptor-mediated endocytosis in 
which a low pH might be required (Kreutz and Ackermann, 1996). However, the 
structural components of PRRSV that mediates attachment and internalization 
to these cells have not yet been identified. At the cellular level, resistance or 
susceptibility to viral infection can be determined at any step, from attachment to 
cellular receptor and internalization, to proper intracellular assembly and release 
of virions. Thus, although the presence of specific viral receptor molecules at 
the cell surface usually dictates tropism and correlates with virus replication, 
other cellular factor (s) might be necessary to confer susceptibility to infection. 
In the present study, we present evidence that PRRSV replication in 
various cell lines might be restricted at different stages of infection: resistance of 
most cells to PRRSV infection is determined at the cell membrane level and can 
be overcome, in some cells, by transfecting viral RNA; in contrast, the resistance 
of Vero cells to PRRSV infection occurs following virus internalization but prior 
to RNA replication. 
2. Material and methods 
2.1. Virus and Cells 
The U.S. isolate of PRRSV ATCC VR-2332 (Benfield et al., 1992; Collins et 
al., 1992) has been used in these experiments. PRRSV was propagated in MARC-
145 cells (Kim et al., 1993) cultured in Eagle's minimal essential medium (EMEM) 
supplemented with 10% fetal calf serum (PCS) and gentamicin sulfate (0.05 
mg/ml). The remaining cells (baby hamster kidney, BHK-21; Crandell-Reese 
feline kidney, CRFK; Hamster kidney, Hak; Madin-Darby bovine and caiiine 
kidney, MDBK and MDCK respectively; porcine kidney, PK-15; swine testis, ST; 
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and African green monkey kidney, Vero) have been maintained in liquid 
nitrogen in our laboratory. These cells were propagated in F-15 minimal 
essential media (MEM) supplemented with 5% PCS and 0.05 mg/ml of 
gentamicin sulfate. 
2.2. Virus binding assays 
The ability of PRRSV to bind to several cell lines was determined by 
measuring the amount of infectious virus that bound to the cells or by detection 
of biotinylated viral proteins that became cell associated following binding of 
biotinylated virus. 
To determine cell-associated infectious virus, cells grown in 24-well plates 
were treated for 30 min with 1 (iM phenylarsine oxide (PAO) to inhibit 
endocytosis (Gibson et al., 1989). The media containing PAO was removed, and 
the cells were incubated with PRRSV at a multiplicity of infection (m.o.i) of 5 cell 
culture infectious dose (CCID50) for 1 h at 37°C. The virus inoculum was 
removed and the cells washed 5 times with EMEM. Finally, 1 ml of EMEM was 
added to the cells, which were then submitted to 3 cycles of freezing/thawing to 
release bound viruses. The amoimt of virus present on the cell extract was 
determined by inoculating MARC-145 cells grown in 96-well plates. 
Alternatively, virus binding was determined by using biotinylated virus. 
PRRSV was purified through cesium chloride gradient (Meng et al., 1994) and 
biotinylated with biotinamidocaproate N-hydroxysuccinamide ester (Amersham, 
Arlington Heights, XL). Cells grown in 48-well plates were treated with 1 |iM PAO 
as described above, and incubated with biotinylated virus for 1 h at 37°C. The 
virus inocula were removed and the cells were washed as above. The cells were 
then lysed under reducing conditions (5% 6 mercaptoethanol) and analyzed by 
SDS-PAGE as described below. 
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2.3. Virus internalization assays 
To determine virus internalization, cells were treated with 40 
chloroquine (Ohkuma and Poole, 1978) for 30 min prior to addition of 
biotinylated virus. Following incubating and washing steps as described above, 
cells were collected by trypsinization, pelleted by centrifugation and washed once 
more prior to lysis under reducing conditions. 
Alternatively, for MARC-145 and Vero cells, an additional internalization 
assay was conducted essentially as described by Asanaka and Lai (1993): Cells were 
incubated with PRRSV at an m.o.i. of 5 CCID50 for 1 h at 4°C. The cells were 
washed 5 times with cold phosphate buffered saline (PBS) and incubated at 37°C 
with pre-warmed media. At various times following the temperature shift, the 
cells were washed with cold PBS and treated with Proteinase K (0.5 mg/ml) at 4°C 
for 45 min. The cells were collected with an equal volume of PBS containing 
5% bovine serum albumin and 75 Hg/ml of phenylmethylsulphonyl-fluoride 
(PMSF). The cells were then pelleted, washed in EMEM and finally resuspended 
in 1 ml of EMEM. Internalized viruses were released following 3 cycles of 
fireezing/thawing the cells. Cellular debris were pelleted by centrifugation 
(10,000 X g), and viruses in the supernatant were quantitated by a plaque assay; 
briefly, aliquots of ten-fold dilution of virus from the internalization assay were 
inoculated in MARC-145 cells grown in 6-well plates and incubated for 1 h at 
37°C. The virus inocula were then removed and the cells were covered with 
EMEM containing 0.5% melted agarose. After 4 days, the agar was removed and 
the cells fixed with methanol for 10 min. Plaques were counted following 
staining by crystal violet. 
2.4. Virus replication assay 
To determine virus replication in different cell lines, cells in 8-well 
chambers were inoculated with virus and fixed 16 h post infection (p.i.) for 
indirect fluorescent antibody (IFA) staining. Fixed cells were incubated with anti-
PRESV porcine antiserum, followed by a FTTC-conjugated goat anti-pordne 
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immunoglobulin (Mengeling et al., 1995), and observed for fluorescence. 
2.5. Polyethylene glycol (PEO-mediated virus entry 
Porcine reproductive and respiratory syndrome virus was adsorbed to 
various cell lines (m.o.i. of 5) at 4®C for 1 h. Unbound viruses were removed by 
washing the cells as described above, using cold media. One set of cells was 
incubated for 1 min with 1 ml of 50% (w/v) pre-warmed PEG 1500 (1500 mol. wt., 
Carbovax) to induce virus-cell fusion as described elsewhere (Asanaka and Lai, 
1993). A second set of cells was treated similarly in the absence of PEG (EMEM 
only). The cells were then incubated with EMEM at 37°C for 2 h. The cell 
medium was then replaced by fresh medium, and the virus yield in the 
supernatant of these cells, at 20 h following fusion, was determined by titration 
on MARC-145 ceUs. 
2.6. Viral RNA extraction and transfection of cells 
The viral RNA used for transfection was obtained from virus pelleted 
from the supernatant of MARC-145 infected cells (140000 x g for 2 h). The virus 
pellet was resuspended in PBS, and the RNA extracted with TRIzol LS reagent, as 
recommended by the manufacturer (GIBCO, BRL) using 10 |ig of tRNA as carrier 
to precipitate the viral RNA. The RNA pellet was then resuspended in water 
(0.05 M-g/ul) and stored at -70°C. Aliquots of 20 |xl (1 |ig) were mixed with 75 ^1 of 
serum-free EMEM and 5 ^il of lipofectin (1 mg/ml; GIBCO, BRL), gently mixed 
and incubated on ice for 15 min. Prior to transfection, the cell monolayers (SO-
SO®/© confluent) were washed twice and incubated for 15 min in serum-free 
media. The media was removed and 900 |il of fresh, serum-free media added to 
the cells. The RNA-lipofectin mixture (100 |il) was then added to the cells, 
followed by incubation at room temperature for 1 h on an orbital platform. The 
RNA-lipofectin mixture was removed, and the cells washed twice and incubated 
with EMEM at 37®C. To determine the production of infectious viruses, aliquots 
were collected from the supernatant of transfected cells at 24 and 48 h post-
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transfection and used to inoculate MARC-145 cells. One set of cells was examined 
for cytopathic effect, and a second set was used for IFA staining. 
2.7. Sodium dodecyl sulfate-polyacrylamide gel electrophorese (SDS-PAGE) and 
western blot 
A 10 |jI aliquot of cell lysate from the binding and internalization assays 
with biotinylated virus was analyzed by discontinuous SDS-PAGE (Hames, 1981) 
using a mighty-small gel system (Hoefer Scientific Instnunents, San Francisco, 
CA). The stacking and resolving gel contained 5% and 15% acrylamide, 
respectively. Proteins were transferred to nitrocellulose papers (Towbin et al., 
1979) using a semi-dry apparatus (Bio-Rad, Hercules, CA) following the 
manufacturer's instructions. Nitrocellulose blots were blocked by using 5% 
(w/v) of dry low fat milk in PBS containing 0.1% Tween 20 (PBST). The presence 
of biotinylated viral proteins was detected with streptavidin-horseradish 
peroxidase conjugate, followed by chemiluminescence detection according to 
instructions (Amersham). 
3. Results 
3.1. PRRSV adsorption to cells 
Replication of PRRSV has been shown to be restricted to a few established 
cell lines, namely MARC-145 (Kim et al., 1993), CI 2621 (Collins et al., 1992) and 
CRL 11171 (Meng et al., 1994). Although PRRSV has a single animal host and a 
narrow cell tropism, no attempts have yet made to determine the cause of 
resistance to replication in most cells lines. Previously, we have shown that 
PRRSV enters MARC-145 cells through endocytosis, followed by a low pH-
dependent step (Kreutz and Ackerman, 1996). Here, we performed a series of 
experiments using various cells lines to determine the cause of resistance to 
PRRSV replication in these cells. Preliminary experiments determined that 
PRRSV binding at 4®C was less efficient (>80%) than binding at 37°C. Thus, most 
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experiments were performed by using PAO treated ceils. Under the conditions 
used here (1 [iM PAO), endocytosis is blocked (Gibson et al., 1989) and PRRSV 
does not infect the cells (Kreutz and Ackerman, 1996). Thus, to determine virus 
binding, cells were treated with PAO and incubated with virus, and the amount 
of infectious virus or biotinylated virus that remained cell-associated was 
determined. 
To ascertain of the binding ability of biotinylated virus, an initial 
experiment was performed in which MARC-145 cells were incubated with 
increasing concentration of biotinylated virus. The protein profile obtained from 
biotinylated viruses following absorption to MARC-145 cells is demonstrated in 
Fig. 1 (A). The potential viral structural proteins were identified and are 
designated as proposed by Van Nieuwstadt et al. (1996). The band observed 
below the N protein might represent a subproduct of the nucleocapsid (Mardassi 
et al., 1996; Drew et al., 1995; Meulenberg et al., 1995). Binding to MARC-145 cells, 
as demonstrated in Fig. 1 (B), increased with virus input, indicating specificity of 
binding (for clarity, only the M protein is shown here). In addition, the presence 
of biotin molecules did not affect virus infectivity, as determined by titration 
prior to emd following virus biotinylation (data not shown). 
The amount of virus that bound to each cell line and could be recovered 
as infectious particles is demonstrated in Fig. 2 (A). For comparison, binding to 
MARC-145 cells, which is permissive to PRRSV infection, was considered as 
100%. The data shown in Fig. 2 (A) demonstrate that besides binding to MARC-
145 cells, PRRSV bound also to the nonpermissive Vero cells. Virus binding to 
the remaining cells was considered non-specific in that it was less than 5% when 
compared to MARC-145 cells. 
However, because this experiment determined the amount of virus that 
bound to the cells and could be recovered as infectious virions, there was the 
possibility that PRRSV could bind to some ceUs and fuse at the cell membrane or 
became inactivated by some cellular component; in this situation, virus binding 
would not be detected. Thus, additional binding experiments using biotinylated 
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virus were performed to detect even viruses that might have fused at the cell 
membrane and/or that become inactivated by cellular components. Similarly to 
the results obtained from the previous binding experiment (Fig. 2 (A)), binding 
of biotinylated virus could not be demoristrated in any cell tested except for 
MARC-145 and also Vero cells, (Fig. 2 (B)). These results suggests that PRRSV 
replication might be restricted by the absence of specific cell surface molecules 
that mediate virus binding. However, as in Vero cells, multiple factors besides a 
functiorial receptor may be involved in allowing virus entry and replication. 
3.2. PRRSV enters but does not replicate in Vero cells 
Next, the ability of cells to internalize virus was investigated (Fig. 3). 
Biotinylated viruses were incubated with cells, and the incorporation of 
biotinylated viral proteins were detected by SDS-PAGE, as described in Material 
and Methods. As expected, biotinylated viral proteins were not detected in those 
cells in which virus was unable to bind. However, this assay demonstrated that 
PRRSV binding to Vero cells was followed by virus internalization. 
However, the above experiments did not indicate whether PRRSV entered 
Vero cells by fusion at the cell membrane or by receptor-mediated endocytosis. 
Thus, the fate of virus internalized in MARC-145 and Vero cells was determined. 
Virus were allowed to attach to the cells for 1 h at 4°C, and the temperature 
shifted to 37°C to allow virus entry. At specific times following the temperature 
shift, the cells were treated with proteinase K at 4''C to remove viruses at the cell 
surface. The cells were then disrupted to release internalized viruses, which 
were then quantitated by plaque assay as described in Materials and Methods. In 
this experiment (Fig. 4), Vero cells bound virus less efficiently than MARC-145 
cells, in contrast to binding at 37®C (Fig. 2 (A)). As demonstrated, PRRSV was 
internalized as infectious virus by both MARC-145 and Vero cells. The amount 
of virus internalized by MARC-145 and Vero cells peaked at 15 and 30 min 
respectively, decreasing substantially by 2 h following the temperature shift. This 
result indicated that both MARC-145 and Vero cells internalized PRRSV as 
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intact, infectious virions, whicii is consistent with the receptor-mediated entry 
mechanism. 
To determine whether synthesis of PRRSV proteins occurred following 
incubation with virus, infected cells were fixed at 16 h p.i. for immunostaining 
with porcine anti-PRRSV senmi. As demonstrated (Fig. 5 (A)), s)mthesis of viral 
proteins was exclusively detected in MARC-145 cells. Fluorescent antibody 
stained Vero cells were not detected (Fig. 5 (B)), which was similar to the result 
obtained with the remaining cells used in this study (not shown). Taken 
together, these results indicate that the resistance to PRRSV replication in Vero 
cells resides in a step following virus binding and internalization, but prior to 
protein expression. 
3.3. Resistance to PRRSV replication occurs during an early stage of viral 
infection of cells 
To further investigate the mechanism of cell resistance to PRRSV 
infection, we attempted to induce virus-cell fusion using PEG. In this 
experiment, cells were incubated with virus at 4°C, and virus-cell fusion was 
induced by incubating the ceils for 1 min with pre-warmed media (37°C) in the 
presence of PEG. A parallel experiment was performed in which cells were 
incubated with warm media in the absence of PEG. Virus replication was 
determined by measioring the virus yield in the supernatant of cells at 20 h 
following PEG treatment. Virus replication occurred in MARC-145 cells in the 
absence or in the presence of PEG (Table 1). Viruses were obtained for the 
supernatant of Vero cells only following PEG treatment, indicating that the 
intracellular milieu of Vero cells is fully permissible to PRRSV replication. No 
virus yield was obtained from other cell lines either following incubation with 
or without PEG. 
However, because PEG mediates fusion of viral envelope and cell 
membrane only when they are closely associated (Hoekstra et al., 1989), this 
experiment could not demonstrate whether cells other than MARC-145 and 
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Vero were permissible to infection once the cell membrane barrier was bypassed. 
Therefore, cells were transfected with purified viral RNA to determine if the 
intracellular milieu sustained viral replication. Transfection of cells with viral 
RNA induced the production of infectious viruses from several cells (Table 1). 
Taken together, these results indicated that the resistance of Vero cells to PRRSV 
replication could be overcome by PEG-mediated entry or RNA transfection, 
indicating that the resistance of Vero cells resides following internalization but 
prior to RNA replication. In addition, failure to detect virus replication in the 
remairung cells indicated that induction of fusion by PEG requires a close contact 
between viral envelope and cell membrane. Transfection of some cells with 
purified RNA and the release of irifectious virus particles indicated that the 
intracellular milieu of these cells are fully permissible to PRRSV replication. In 
addition, it indicated for the first time that the PRRSV genome is iiifectious per 
se (of positive polarity) as previously suggested (Conzelman et al., 1993; 
Meulenberg et al., 1993). In contrast, failure to detect infectious virus after 
transfection of some cells might indicate that either the intracellular milieu of 
these cells are resistance to PRRSV replication or that the transfection conditions 
are not optimized for these cells. 
4. Discussion 
Infection of cells by viruses initiates by interaction of viral attachment 
proteins with specific receptors molecules on the cell stirface (Marsh and 
Helenius, 1989). Although the presence of viral receptors on target cells is an 
important determinant of susceptibility to infection, it is becoming more evident 
that other cellular factors play a crucial role in determining virus entry and 
replicatiori. Several recent studies have indicated that the expression of a virus-
binding molecule is not the sole factor dictating susceptibility to infection. For 
instance, expression of a functional receptor for mouse hepatitis virus (MHV) by 
murine cells does not correlate with susceptibility to iiifection (Yokomori et al.. 
91 
1993); entry of MHV into these cells and subsequent virus uncoating depend on 
several cellular factors (Asanaka and Lai, 1993). Similarly, cell expression of the 
CD4 molecule is not sufficient to ensure himian immimodefidency virus entry 
and replication (Tersmette et aL, 1989; Qiesebro et al., 1990). In this paper, we 
show that the restriction of PRRSV replication in most cells can occur at several 
distinct steps: first, failure of virus binding to cellular receptors, as observed in 
most cells tested; second, a step following virus binding and internalization, 
most likely at the uncoating level, as deduced from the experiments involving 
Vero cells; and third, an intracellular restriction to PRRSV replication might 
also occur, since no infectious viruses were recovered in some cells following 
RNA transfection. 
Failure of PRRSV replication in several cell lines has been extensively 
reported (Wensvoort et al., 1991; Collins et al., 1992; Mardassi et al., 1993; Meng et 
al., 1996), but the cause of resistance to replication in cells in culture has not yet 
been investigated. The PRRSV-resistant Vero cells allowed virus binding almost 
as efficiently as did the susceptible MARC-145 cells, indicating that the resistance 
of Vero cells is not due to failure of virus attachment. Because MARC-145 cells 
are susceptible to PRRSV replication (Kim et al., 1993), binding to this cell line 
can be regarded as being specific. However, lack of PRRSV replication in Vero 
cells is not an indication that binding, as observed in these experiments, was 
mediated by nonspecific interaction between viral protein(s) and cell surface 
molecules. If a neutralizing monoclonal antibody to PRRSV was available, it 
would be possible to demonstrate whether binding to Vero cells was mediated by 
the same binding site of the viral protein that mediates binding to MARC-145 
cells. In contrast, binding to the other cell lines tested might be considered 
nonspecific for two reasons: first, binding, as measured by cell-associated 
infectious virus was less than 5% in comparison to MARC-145 and even Vero 
cells, and could not be demonstrated by using biotinylated virus, and second, no 
infectious virus was recovered following incubation of infected cells with PEG. 
Thus, because PEG does not induce generalized fusion between the viral 
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envelope and cell membrane, except when in close contact (Hoekstra et al., 1989), 
it becomes evident that the virions recovered from these cells following binding 
were not closely associated with cellular molecules, as would be expected from a 
specific interaction between virus attachment protein and cellular receptors. In 
contrast, the opposite observation applies to Vero and MARC-145 cells in which 
viral replication occurred following a brief incubation with PEG, indicating that 
the binding step brought virions close to the cell membrane surface and 
accessible to the fusion activity of PEG. 
Furthermore, this study indicates that PRRSV binding to Vero cells was 
followed by virus internalization. Viruses were recovered in an infectious form 
from cell extracts indicating that they were actively internalized by the endocytic 
pathway, as we recently suggested (Kreutz and Ackermann, 1996). There is 
evidence that another arterivirus, LDV, is internalized by mouse macrophages 
through a similar mechanism (Kowalchyk and Plagemann, 1985). Had the virus 
entered by fusing the envelope at the cell membrane surface, as observed with 
some enveloped viruses (Marsh and Helenius, 1989), removal of the virus 
envelope would render the virus non-infectious and imdetectable in this assay. 
However, infectious viruses were detected even at 90 min following the 
temperature shift, suggesting that virus entry occurred by endocytosis and is an 
asynchronous process, as previously indicated (Kreutz and Ackermarm, 1996). 
Because viruses internalized by Vero cells become gradually less detectable but do 
not replicate, the fate of these viruses is uncertain. This study suggests that 
PRRSV is trapped inside Vero cell vesicles wherein a second receptor or cellular 
molecule is absent or defective, preventing virus uncoating and release of the 
nucleocapsid to the cytoplasm. This observation is supported by the fact that PEG-
mediated fusion of PRRSV envelope with the cytoplasmic membrane of Vero 
cells, releasing the viral nucleocapsid to the intracellular compartment, leads to 
the production of infectious viruses. 
Most cells used in this study failed to bind and internalize PRRSV, 
suggesting that the absence of viral receptor molecules restrict virus replication 
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in these cells. However, as in Vero cells, a secondary, intracellular factor(s) 
besides a functional receptor on the cell surface, could play a major role in 
preventing virus replication. Thus, by transfecting cells with purified viral RNA 
with subsequent release of infectious virus, it became evident that the 
intracellular milieu of some cells is permissible to PRRSV replication and, most 
important, that the viral genome is infectious per se (of positive polarity) as 
predicted from the nucleotide sequence analysis and the presence of a 
polyadenylated 3' end (Conzelmann et al., 1993; Meulenberg et al., 1993). In 
addition, it establishes that the absence of appropriate molecules in the cell 
surface is the major cause of resistance to infection by PRRSV. Furthermore, it 
suggests that multiple cellular factors might be involved in virus entry and 
uncoating. Failure to recover infectious virus from transfected MDBK, MDCK, 
PK-15 and ST cells suggests that an intracellular factor may be absent or may 
inhibit replication of viral RNA. However, because cell susceptibility to 
traiisfection with preformed liposomes varies, viral RNA may not have been 
efficiently transfected into those cells from which no progeny virus were 
recovered. Nonetheless, it would be of interest to determine whether an 
intracellular factor would indeed be required to initiate replication of the PRRSV 
genome. 
The requirement of several cellular factors to allow virus enfry and 
uncoating has been suggested by studies involving other unrelated viruses. 
Recently, we showed that pestiviruses require a common cellular factor to enter 
MDBK cells, and bind but fail to enter CRIB-1 cells, a clone of MDBK cells (Flores 
et al., 1996). Similarly, several other uiurelated viruses fail to replicate in cells 
despite the presence of a functional receptor that mediates binding (Kaner et al., 
1990; Wickham et al., 1993; Yokomori et al., 1993). Interestingly, MARC-145 and 
Vero cells are different clones of African green monkey kidney cells, but differ in 
their ability to assist in virus infection, suggesting that a specific cellular 
component is altered or absent. It is possible that PRRSV binding and uncoating 
is mediated by one or more viral structural proteins that interact with multiple 
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domains of a single ceEular receptor in both MARC-145 and Vero cells, but one 
such domain is defective in Vero cells. 
Thus, the identification of the viral and cellular molecule(s) involved in 
PRRSV interaction with cells will represent a critical point in understanding one 
major mechanism that dictates cellular tropism and pathogenesis of PRRSV. 
Acknowledgements 
The author thanks Dr. William L. Mengeling for supporting this study 
and reviewing the manuscript. Appreciation is extended to Dr. Prem S. Paul, 
Dr. Donald K Beitz, Dr. Mark Ackerman and Dr. Susan Lamont for their critical 
review of this manuscript Additional thanks to Mr. Gene Hedberg for graphics 
and Ms. Sue Ohlendorf for admirustrative assistance. 
References 
Asanaka, M. and Lai, M.M.C. (1993) Cell fusion studies identified multiple 
cellular factors involved in mouse hepatitis virus entry. Virology 197, 732-
741. 
Benfield, D.A., Nelson, E., Collins, J.E., Harris, L., Goyal, S.M., Bobinson, D., 
Christianson, W.T., Morrison, R.B., Gorcyca, D. and Chladek, D. (1992) 
Characterization of swine infertility and respiratory syndrome (SIRS) virus 
(isolate ATCC VR-2332). J. Vet. Diagn. Invest. 4,127-133. 
Chesebro, B., Buller, R., Portis, J. and Wehrly, K. (1990) Failure of human 
immimodeficiency virus entry and infection in CD4-positive human brain 
and skin cells. J. Virol. 64, 215-221. 
95 
Collins, J.E., Benfield, D.A., Christianson, W.J., Harris, L., Hennings, J.C., Shaw, 
D.P., Goyal, S.M., McCuUough, S., Morrison, R.B., Joo, H.S., Gorqrca, D.E. and 
Chladek, D.W. (1992) Isolation of swine infertility and respiratory syndrome 
virus (isolate ATCC VR-2332) in North America and experimental 
reproduction of the disease in gnotobiotic pigs. J. Vet. Diagn. Invest. 4,117-126 
Conzelmaim, K., Visser, N., Van Woensel, P. and Thiel, H. (1993) 
Molecular characterization of porcine reproductive and respiratory syndrome 
virus, a member of the arterivirus group. Virology 193, 329-339. 
De Vries, A.A.F., Post, S.M., Raamsman, M.J.B., Horzinek, M.C. and Rottier, 
P.J.M. (1995) The two major envelope proteins of equine arteritis virus 
associate into disiilfide-linked heterodimers. J. Virol. 69, 4668-4674. 
Done, S.H., Paton, D.J. and White, M.E.C. (1996) Porcine reproductive and 
respiratory syndrome (PRRS): a review, with emphasis on pathological, 
virological and diagnostic aspects. Br. Vet. J. 152,153-174. 
Drew, T.W., Meulenberg, J.J.M., Sands, J.J. and Paton, D.J. (1995) Production, 
characterization and reactivity of monoclonal antibodies to porcine 
reproductive and respiratory syndrome virus. J. Gen. Virol. 76, 1361-1369. 
Faaberg, K.S., Even, C., Palmer, G.A. and Plagemaim, P.G.W. (1995) Disulfide 
bonds between two envelope proteins of lactate dehydrogenase-elevating 
virus are essential for viral infectivity. J. Virol. 69, 613-617. 
Flores, E.F., Kreutz, L.C. and Donis, R.O. (1996) Swine and riuninant pestiviruses 
require the same cellular factor to enter bovine cells. J. Gen. Virol 77,1295-
1303. 
96 
Gibson, A.E., Noel, R.J., Herlihy, T. and Ward, W.F. (1989) Phenylarsine oxide 
inhibition of endocytosis: effects on asialofetuin internalization. Am. J. 
Physiol. 257, C182-C184. 
Goyal, S.M (1993) Porcine reproductive and respiratory virus. J. Vet. Diagn. 
Invest. 5, 656-664 
Hames, B.D. (1981) An introduction to polyacrylamide gel electrophoresis. In; 
B.D. Hames and D. Rickwoods (Eds.), Gel Electrophoresis of Proteins: A 
Practical Approach, pp. 1-91, IRL Press, Oxford. 
Hoekstra, D., BQappe, K., Hoff, H and Nir, S. (1989) Mechanism of fusion of 
sendai virus: role of hydrophobic interaction and mobility constraints of viral 
membrane proteins. Effect of polyethylene glycol. J. Biol. Chem. 264, 6786-
6792. 
Kaner, R.J., Baird, A., Mansukhani, A., Basilico, C., Summers, B.D., Florkiewicz, 
R.Z. and Hajjar, D.P. (1990) Fibroblast growth factor receptor is a portal of 
cellular entry for herpes simplex virus type-1. Science 248,1410-1413. 
Kim, H.S., Kwang, J., Yoon, I.J., Joo, H.S. and Frey, M.L. (1993) Enhanced 
replication of porcine reproductive and respiratory syndrome (PRRS) virus 
in a homogeneous subpopulation of MA-104 cell line. Arch. Virol. 133, 477-
483. 
Kowalchyk, K. and Plagemaim, P.G.W. (1985) Cell surface receptors for lactate 
dehydrogenase-elevating virus on subpopulation of macrophages. Virus 
Research 2,211-229. 
97 
BCreutz, L.C and Ackermann. M.R. (1996) Porcine reproductive and 
respiratory syndrome virus enters ceils through a low pH-dependent 
endocytic pathway. Virus Research 42,137-147. 
Mardassi, H., Athanassious, R., Mounir, S. and Dea, S. (1993) Porcine 
reproductive and respiratory syndrome virus: morphological, biochemical 
and serological characteristics of Quebec isolates associated with acute and 
chronic outbreaks of porcine reproductive and respiratory syndrome. Can. J. 
Vet. Res. 58, 55-64. 
Mardassi, H., Massie, B. and Dea, S. (1996) Intracellular synthesis, processing and 
transport of proteins encoded by ORFs 5 to 7 of porcine reproductive and 
respiratory syndrome virus. Virology 221, 98-112. 
Marsh, M. and Heleruus, A. (1989) Virus entry into animal cells. Adv. Virus Res. 
36,107-151. 
Meng, X., Paul, P.S. and Halbur, P.G. (1994) Molecular cloning and nucleotide 
sequencing of the 3'-terminal genomic RNA of the porcine reproductive 
and respiratory syndrome virus. J. Gen. Virol. 75, 1795-1801. 
Meng, X., Paul, P.S., Halbur, P.G. and Lum, M.A. (1996) Characterization of a high-
virulence US isolate of porcine reproductive and respiratory syndrome 
virus in a continuous cell line, ATCC CRL 11171. J. Vet. Diagn. Invest. 8, 374-
381. 
Mengeling, W.L., Lager, K.M. and Vorwald, A.C. (1995) Diagnosis of porcine 
reproductive and respiratory syndrome. J. Vet. Diagn. Invest. 7, 3-16. 
98 
Meulenberg, Hulst, M.M., De Meijer, EJ., Moonen, P. Den Besten, 
A., De Kluyver, E.P., Wensvoort, G. and Moormann, R.J.M. (1993) Lelystad 
virus, the causative agent of porcine epidemic abortion and respiratory 
syndrome (PEARS), is related to LDV and EAV. Virology 192, 62-72. 
Meulenberg, Den Besten, A.P., De BQuyver, E.P., Moormann, R.J.M., 
Schaaper, W.M.M. and Wensvoort, G. (1995) Characterization of proteins 
encoded by ORFs 2 to 7 of Lelystad virus. Virology 206,155-163. 
Ohkuma, S. and Poole, B. (1978) Fluorescent probe measurement of the 
intralysosomal pH in living cells and the perturbation of pH by various 
agents. Proc. Nati. Acad. Sd. U.S.A. 75,3327-3331. 
Plageman, P.G.W. and Moening, V. (1992) Lactate dehydrogenase-elevating 
virus, equine arteritis virus, and simian hemorrhagic fever virus: a new 
group of positive-strand RNA viruses. Adv. Virus Res. 41, 99-192. 
Tersmette, M., Van Dongen, J.J.M., Qapham, P.R., De Goede, R.E. Y., Wolvers-
Tettero, LL.M., Van Kessel, A.G., Huisman, J. G., Weis, R.A. and Miedema, F. 
(1989) Human immunodeficiency virus infection studied in CD4-expressing 
human-mxirine T-cell hybrids. Virology 168, 267-273. 
Towbin, H., Staehelin, T. and Gordon, J. (1979) Electrophoretic transfer of 
proteins from polyacrylamide gels to nitrocellulose sheets: procedure and 
some applications. Proc. Nati. Acad. Sd. U.S.A. 76,4350-4354. 
99 
Van Nieuwstadt, A.P., Meiilenberg, Van Essen-Zandbergen, A., Den 
Besten, A.P., Bende, R. J., Moormann, R.J.M. and Wensvoort, G. (1996) 
Proteins encoded by open reading frames 3 and 4 of the genome of Leiystad 
virus (Arteriviridae) are structiirai proteins of the virion. J. Virol. 70, 4767-
4772. 
Wensvoort, G., Terpstra, C., Pol, J.M.A., Ter Laak, E.A., Bloemraad, M., De 
Kluyver, E.P., Kragten, C., Van Buiten, L., Den Besten, A., Wagenaar, P., 
Broekhuijsen, J.M., Moonen, P.L.J.M., Zestra, T., Deboer, E.A., Tibben H.J., De 
Jong, M.F., Van't Veld, P., Groeland, G.L.R., Van Gennep, J.A., Voets, 
M.T., Verheijden, J.M.H. and Braamskamp, J. (1991) Mystery swine disease in 
the Netherlands; the isolation of Leiystad virus. Vet. Q. 13,121-130. 
Wickham, T.J., Mathias, P., Cheresh, D.A. and Nemerow, G.R. (1993) Integrins 
ttvCs and Oyfis promote adenovirus internalization but not virus attachment. 
Cell 73,309-319. 
Yokomori, K., Asariaka, M., Stohlman, S.A. and Lai, M.M.C. (1993) A spike 
protein-dependent cellular factor other than the viral receptor is required for 
mouse hepatitis virus entry. \^ology 196, 45-56. 
100 
G p 3  
G p 4 .  
G p 2 .  
G p 5 -
M-
N . 
- 4 6  
- 14.3 
B 
Figure 1. Protein profile of biotinylated PRRSV and binding specificity to 
cells. (A) Protein profile of MARC-145 cell-bound biotinylated 
PRRSV, analysed by SDS-PAGE followed by western blot 
detection of biotinylated proteins using HRP-conjugated 
streptavidin. Proteins corresponding to the nucleocapsid N, 
membrane M and potential glycoproteins (Gp) 2 to 5 are 
indicated. The position of moleoilar weight standards is 
indicated at right. (B) specificity of biotinylated PRRSV 
binding to cells. MARC-145 cells were treated with PAO and 
incubated with 1,10 or 20 jil of biotinylated virus, and anlyzed 
as above. Only the M protein is shown here. 
101 
cs 
I 
X CQ 
u. Q£ 
a 
03 Q U Q 
a. 
Cell type 
E-
C/2 u > 
IT! TT 
I 
u 
ai 
< 
Figure 2. PRRSV adsorption to several cell lines. (A) Binding of PRRSV to 
various cell lines measured as cell-bound infectious virus, as described 
in material and methods. The amoiint of infectious virus bound to 
each cell was determined by titrating the virus content of cells extract in 
MARC-145 cells. Binding to MARC-145 cells v^as considered as 100% 
for comparison purposes. (B) Binding of biotinylated PRRSV to cells, 
determined by immunoblot detection of ceil-assodated biotinylated 
viral proteins (only the M protein is shown) by immunoblot using 
HRP-conjugated streptavidin, as described in material and methods. 
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Figure 3. Internalization of biotinylated PRRSV by different cells. 
Cells were treated and incubated with biotinylated virus 
as described in material and methods. The presence of 
internalized biotinylated viral proteins was detected by 
rmmunoblot. 
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Figure 4. Analysis of virus internalized by MARC-145 and Vero cells that could 
be recovered as infectious particles. PRRSV was allowed to bind for 1 h 
at 4°C. Unbound virus was removed by washing and the cells were 
then incubated at 37°C. At various times following the temperature 
shift, the cells were washed with cold PBS and treated with proteinase 
K at 4°C. After disrupting the cells, the virus content in the cell extract 
was analyzed by plaque assay in MARC-145 cells. 
Figure 5. Indirect fluorescent antibody staining of PRFSV-infected cells. 
(A) Vero and (B) MARC-145 cells grown in 8-well chamber were 
infected with PRRSV and fixed at 20 hr p.i. The cells were then 
incubated with a porcine anti-PRRSV polyclonal antibody, 
followed by a FTTC-conjugated goat anti-porcine immunoglobulin. 
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Table 1. Replication of PRRSV in various cell lines following incubation of 
infected cells with PEG, or following transfection of cells with viral 
RNA, as measured by detecting infectious virus in the supernatant of 
cells. 
Virus yielda 
Cell line No PEG PEG RNA transfection 
BHK-21 NDb ND +c 
CRFK ND ND + 
HaK ND ND + 
MDBK ND ND ND 
MDCK ND ND ND 
PK-15 ND ND ND 
ST ND ND ND 
Vero ND + + 
MARC-145 + + + 
a Determined by inoculating the supernatant of these cells into MARC-145 cells 
and observed for CPE and immunostaining. 
b ND, not detected 
c +, positive detection of infectious virus 
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CHAPTER 5. BACULOVIRUS EXPRESSION AND IMMUNOLOGICAL 
DETECTION OF THE MAJOR STRUCTURAL PROTEINS OF PORCINE 
REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS 
Luiz C. Kreutz and William L. Mengeling 
A paper to be submitted to Veterinary Microbiology 
Abstract 
Each of the three major structural proteins (envelope glycoprotein E, non-
glycosylated membrane protein M, and nucleoprotein N) of an American strain 
of porcine reproductive and respiratory syndrome virus (PRRSV) was expressed 
by using a recombinant baculovirus expression system. Insect cells infected with 
the respective recombinant baculovirus synthesized five distinct forms of 
glycoprotein E with a molecular mass (Mr) of either 17,20,23,25, or 26 K, and a 
single form of non-glycosylated protein M and nucleocapsid N with a Mr of 
approximately 21 and 15 K, respectively. Because the number of forms of the 
glycoprotein E was reduced from five to two (20 and 17 K) when iiifected cells 
were treated with tunicamydn, we speculate that the 23, 25 and 26 K forms 
represent different degrees of glycosylation of the same protein, and that the 20 
and 17 K peptides represent non-glycosylated forms with and without, 
respectively, the N-terminal signal sequence. All the proteins were identified by 
inununoblot with convalescent sera from animals infected with an American 
strain of PRRSV, indicating that they were similar to the native proteins. The 
recombinant proteins were purified and used to induce monospecific antisera in 
rabbits. The ability to produce each protein in the baculovirus system provides 
an additional means for their structural and functional characterization. 
108 
1. Introduction 
Pordne reproductive and respiratory syndrome virus (PRRSV) was 
recently isolated and partially characterized (Benfield et al., 1992; Collins et al., 
1992; Wensvoort et al., 1991). It is an enveloped virus with a diameter of 
approximately 65 nm, containing a positive sense, single-stranded RNA genome 
of 15 Kb, which contains eight open reading frames (ORFs) (Conzelmann et al., 
1993; Meulenberg et al., 1993). During infection of cells, subgenomic mRNA 
molecules are transcribed from each ORF, forming a nested set of 3' co-terminal 
transcripts (Conzelmann et al., 1993; Meulenberg et al., 1993). Currently, PRRSV 
is tentatively classified as an arterivirus, along with lactate dehydrogenase-
elevating virus (LDV), equine arteritis virus (EAV) and simian hemorrhagic 
fever virus (Plagemann and Moennig, 1992). Infection of susceptible animals 
with PRRSV induces reproductive failure in pregnant females, increased 
mortality in young animals, and a flu-like syndrome in animals of all ages (Done 
et al., 1996). Other notable biological features of PRRSV infection include a 
resfricted cell tropism (Wensvoort et al., 1991; Collins et al., 1992; Mardassi et al., 
1993; Meng et al., 1996) and the ability to cause asymptomatic, persistent 
infection, even in the presence of circulating antibodies (Goyal, 1993). 
The early immimological response of infected pigs is directed mainly to 
the putative nudeocapsid (N) protein (Nelson et al.,1994), which has common 
epitopes among most PRRSV isolates (Nelson et al., 1994; Drew et al., 1995). 
Subsequently, an antibody response is also observed against two other structural 
proteins, the fransmembrane (M) protein and the envelope (E) glycoprotein 
(Nelson et al., 1994; Yoon et al., 1995). Recently, it has been demonsfrated by in 
vitro translation studies of the European and Canadian isolates of PRRSV that 
the putative E, M and N proteins are encoded by ORF 5, 6 and 7, respectively 
(Mardassi et al., 1995; Meulenberg et al., 1995). Other minor proteii\s have also 
been detected with purified virions (15,18,24), but their role in virus sfructure 
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has not been completely defined. 
Nucleotide sequencing analysis of the 3' end of the viral genome 
demonstrated that there are two genotypes of PRRSV (Meng et al., 1995). The 
predicted structural proteins are different in molecular weight, isoelectric point 
and the nimiber of potential N-glycosylation sites (Conzelmann et al., 1993; 
Meulenberg et al., 1993; Mardassi et al., 1995; Meulenberg et al., 1995; Murtaugh et 
al., 1995). In addition, amino add insertion and deletion occurs in the overall 
sequence. Although extensive nudeotide sequence analysis of the genes 
encoding for structural proteins has been recently reported for a variety of U.S. 
isolates (Meng et al., 1995a; Meng et al., 1995b; Morozov et al., 1995), these 
proteins have not been expressed and characterized. Because PRRSV structural 
proteins are produced at low levels in infected cells, a recombinant baculovirus 
would greatly improve the expression and characterization of these proteins and 
the production of serodiagnostic reagents. In this study, the genomic regions 
encoding for the E, M and N proteins of PRRSV were doned into a baculovirus 
and expressed in insect cells, and the corresponding proteins were subsequently 
characterized and used to induce monospecific antisera. 
2. Materials and Methods 
2.1. Cells and viruses 
Spodoptera frugiperda 21 (sf-21) ceils were propagated in Grace's media 
(Gibco, BRL, Grand Island, NY) supplemented with 10% fetal calf senmi (PCS) 
and gentamidn sulfate (0.05 mg/ml). Porcine reproductive and respiratory 
syndrome virus isolate ATCC VR 2332 (Benfield et al., 1992; Collins et al., 1992) 
was propagated in MARC-145 cells (Kim et al., 1993) grown in Eagle's minimal 
essential media (EMEM) supplemented with 10% PCS and 0.05 mg/ml of 
gentamidn sulfate. 
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2.2. Cloning of PRRSV genes 
The acid-guanidinium method (Chomczynski and Sacchi, 1987) was used 
to extract total RNA from MARC-145 cells mock-infected or infected with 
PRRSV. The genome segments corresponding to ORFs 5, 6 and 7, which encode 
for the putative envelope glycoprotein, membrane, and capsid proteins, 
respectively, were amplified by one-tube reverse transcription polymerase chain 
reaction (RT-PCR) using primers and conditions stated in the legend of figure 1. 
Restriction enzymatic sites were included in the primers to facilitate directional 
cloning of the amplified fragment into the transfer vector. The strategy of 
cloning is schematically represented in figure 1. The RT-PCR amplified genome 
fragments were purified from low melting point agarose gels using glass beads 
(Gene Clean n, BIO 101, La JoUa, CA), digested with the appropriate restriction 
enzyme, and ligated into the transfer vector pVL 1393 (Invitrogen, San Diego, 
CA) digested with the same enzymes. The plasmid vector was amplified in 
bacteria cells, purified (Qiagen, Chatsworth, CA), and the identity of the cloned 
fragment was determined by nucleotide sequencing and further alignment with 
the published sequence of a PRRSV isolate (Meng et al., 1994). 
2.3. Construction of recombinant baculoviruses 
Sf-21 cells were transfected with a mixture of purified transfer vector each 
containing a PRRSV gene and linearized baculovirus DNA (Clontech, Palo Alto, 
CA), according to the manufacturer's instruction. After 4 days of incubation, the 
culture media of transfected cells was serially diluted and plated on monolayers 
of sf-21 cells and incubated for 1 hour. The inoculum was then removed and the 
monolayers overlayed with 1% low melting point agarose in Grace's media. 
After 5 days, recombinant baculovirus plaques were visualized by staining the 
cells with neutral red. Individual viral plaques were selected and amplified in 
sf-21 cells, and the presence of the PRRSV gene in the recombinant baculovirus 
was determined by southern blot of DNA previously digested with restriction 
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enzymes (BamHI and EcoRI) and western blot of proteins from infected cells. 
2.4. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and 
western blot 
One positive recombinant baculovirus for ORF 5, 6 and 7 was selected on 
the basis of Southern and western blots, denoted rBac-5, rBac-6 and rBac-7, 
respectively, and used to characterize its gene product. Sf-21 cells were infected 
with recombinant baculovirus at a multiplicity of infection (m.o.i) of 10 plaque 
forming units (p.f.u)/ml. Recombinant baculovirus-infected insect cells were 
collected at different times post infection (p.i.), washed once in PBS, lysed under 
reducing conditions (5% 12-mercaptoethanol) and analyzed by SDS-PAGE 
(Hames, 1981). Wild type baculovirus-infected or mock-infected cells were 
processed similarly. Following SDS-PAGE, the gels were stained by Coomassie 
blue or the proteins were transferred to nitrocellulose (Towbin et al., 1979), by 
using a semi-dry apparatus (Bio-Rad, Hercules, CA). The nitrocellulose blots 
were saturated with PBS containing 3% fish gelatin and 0.05% Tween 20. 
Recombinant proteins were detected with porcine anti-PRRSV serxun 
(Mengeling et al., 1995) diluted 1:100 in blocking solution for 1 hr, followed by 
three washes with PBS 1% fish gelatin, 0.05% Tween 20. The blots were then 
reacted with horseradish peroxidase conjugated rabbit anti-swine IgG, washed 
and developed using by 4-chloro-naphthol and hydrogen peroxide (Gersoni, 
1983). Alternatively, MARC-145 infected and non-infected cells lysates were 
resolved by SDS-PAGE as above, transferred to nitrocellulose and used to 
determined the reactivity of rabbit monoespedfic antisera to the recombinant 
proteins (see below). In this case, blots were saturated with 5% norifat dry milk 
in PBS containing 0.05% Tween 20 (PBST) for 1 hr at room temperature, or 
overnight at 4®C. The blots were then reacted with rabbit antisera diluted in PBST 
5% dry milk and allowed to react for 2 hr at room temperature, followed by 3 
washes of 15 min each in PBST. A HRP-conjugated anti-rabbit sera (ECL western 
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blot Kit, Amersham) was diluted in PBST and 5% dry milk, and incubated with 
the blots for 1 hr at room temperature, followed by 2 rinses and 5 washes of 15 
min each with PBST. Bound antibody was detected by using chemiluminescence 
according to instructions (ECL, Amersham). 
2.5. Purification of recombinant protein and production of gene-specific 
polyclonal serum 
Recombinant baculovirus infected sf-21 cells lysates were separated by 15% 
SDS-PAGE as described above, and the bands corresponding to the recombinant 
PRRSV proteins (E, M or N) were excised from the gel and electroeluted as 
described elsewhere (Jacobs and Clad, 1986), using a Schleicher & Schuel 
apparatus. The purity and nature of the eluted proteins were determined by SDS-
PAGE followed by silver staining of the gel and by western blotting using porcine 
hjrperimmune sera, as described above. Monoespecific antisera to PRRSV 
recombinant proteins were produced by inoculating New Zealand albino rabbits 
subcutaneously with approximately 200 ng of purified protein emulsified in 
complete Freund's adjuvant (DIFCO Laboratories). The rabbits were boosted 3 to 
5 times at 14 days intervals, with approximately 80-100 |ig of protein emulsified 
in incomplete Freund's adjuvant (DIFCO Lab.), injected intramuscularly. 
Reactivity of the rabbit antisera was determined by IFA staining and western blot 
assays using PRRSV-infected MARC-145 cells. Monospecific rabbit antisera do the 
gene product of ORFs 5, 6 and 7 were designated anti-5, anti-6 and anti-7, 
respectively 
3. Results 
3.1. Strategy of cloning and identification of positive recombinants 
The strategy for the construction of recombinant baculovirus is 
schematically demonstrated in figure 1. Nucleotide sequencing analysis 
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confirmed that the inserted fragment contained the entire coding sequence for 
viral ORFs 5, 6 or 7 (data not shown). Following identification of positive clones, 
the expression of the recombinant proteins in sf-21 cells was monitored by 
collecting infected cells at different times p.i. and analyzing the protein content 
by SDS-PAGE and western blots (see below). Sf-21 cells infected at a m.o.i. of 10 
with recombinant baculoviruses rBac-5 and rBac-6 showed pronounced 
cytopathic effect (CPE) at approximately 36 hours p.i. and Q?E was complete by 48 
hours for rBac-5 and by 60 hours p.i for rBac-6. Sf-21 cells infected with rBac-7 
showed signs of infection approximately 36 to 48 hours p.i. and pronounced CPE 
approximately 96 to 120 hours p.i. 
3.2. Expression of recombinant proteins of PRRSV 
Several distinct polypeptides with a molecular mass (Mr) of approximately 
25-26,23,20 and 17 K were first detected at 24 hours p.i. in lysates of sf-21 cells 
infected with rBac-5, which expressed the putative envelope glycoprotein of 
PRRSV (Fig. 2A). Expression was higher by 48 hours, and further assessment of 
protein expression could not be made because of extensive CPE of the insect cells. 
Following treatment of rBac-5 infected cells with 4 ug/ml of tuiucamycin, the 25, 
26 and 23 K polypeptides observed in untreated infected cells (Fig 2 B, lane C) 
could no longer be detected, while the 20 K protein remained at the same level of 
expression and the 17 K product appeared more prominent (Fig 2 B, lane T). 
The recombinant M protein, first detected at 24 hours p.i. by Coomassie 
blue staining of gels and immunoblots (Fig 2C, arrow and 2D, respectively), and 
had an apparent Mr of 21 K. A similar protein was not detected in mock-infected 
cells (Fig 2C and 2D, Ml). 
The gene product of ORF 7 was expressed similarly and had a Mr of 
approximately 15 K and was clearly visible by Coomassie blue staining of the gel 
(Fig 2 E, lane 48 hr). This protein was expressed to higher levels and for a longer 
period of time (96-120 hours). Immunoblot detection (Fig 2 F) of the putative N 
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protein required less stringent conditions than the other proteins, reflecting 
some loss of antigenicity, most likely because of the denaturing condition of the 
system. In addition, this protein was not efficiently transferred to nitrocellulose 
membranes, as attested by staining the gels after blotting. However, during 
inununoprecipitation assays using gentle disruption of cells, this protein was 
efficiently precipitated by porcine polyclonal (Mengeling et al., 1995) and mice 
monoclonal antibody (Nelson et al., 1994) (data not shown). 
Because the M and N proteins are highly conserved among different 
PBiRSV isolates (Meng et al., 1995a), the potential use of these proteins in 
serological diagnostic of PRRSV infection was investigated by western blot using 
sera samples collected either at birth or at weekly intervals from a piglet that had 
been congenitally infected with PRRSV (Mengeling et al., 1995). The 
immunoblot reactivity obtained (Fig. 3 A and B) had good correlation with the 
indirect immunofluorescent antibody (IFA) titers reported for these sera 
(Mengeling et al., 1995). 
3.3. Identification of PRRSV ORF 5, 6 and 7 encoded proteins in MARC-145 
infected cells using gene specific antiserum 
To determine the reactivity of monospecific antisera produced by 
inoculating rabbits with baculovirus expressed proteiiis, pre- and post-
inoculation sera from the rabbits were analysed for their reactivity to PRRSV 
proteins by western blot and IFA assay by using PRRSV-infected MARC-145 cells. 
Antisera do the gene product of ORF 5 (anti-5) recognized several polj^eptides in 
PRRSV-irifected cells with Mr corresponding to the various glycosylated forms of 
E glycoprotein (Fig. 4, E), similar to those observed in baculovirus-infected insect 
cells; anti-6 and anti-7 sera recognized a single polypeptide with Mr 
corresponding to the M and N proteins, respectively (Fig. 4, M and N). These 
proteiiis were not reactive with pre-inoculation sera and were not detected in 
non-infected MARC-145 cells (Fig. 4, NI). Although additional bands were 
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eventually detected by preimmune sera and by sera collected following 
immunization of rabbits with the recombinant proteins, they were inconsistently 
detected and considered nonspecific. 
By using monospecific antisera to the recombinant proteins and IFA 
staining of infected cells, it was possible to determine the intracellular location of 
the native proteins. Figure 5 A and 5 B demonstrate the reactivity of porcine sera 
to PRRSV-infected or mock-infected cells, respectively. Rabbit sera anti-5 and 
anti-6 indicate that the gene product of ORF 5 and 6 accumulate in the 
perinuclear area (Fig. 5,D, E, respectively), whereas the gene product of ORF 7 is 
found dispersed throughout the cytoplasm of infected cells (Fig. 5, F), which was 
similarly to the pattern reported recently by Mardassi et al. (1996) with the 
Canadian isolate lAF-Klop. A post-immunization sera pool was not reactive 
with MARC-145 non-infected cells (Fig. 5 C). 
4. Discussion 
Recombinant baculoviruses containing the genes encoding for the 
putative E, M or N proteins of PRRSV were constructed and used to express the 
proteins in insect cells. Baculovirus-expressed proteins were detected by both 
Coomassie blue staining of gels and western blot using porcine anti-PRRSV sera, 
which indicated that the recombinant proteins were antigenically similar to the 
proteins produced during virus infection of animal cells. 
Several polypeptides were foimd reactive to porcine hyperinunime sera in 
insect cells infected with rBac-5, which expressed the putative envelope 
glycoprotein. Because expression of at least three forms of this protein (the 26, 25 
and 23 K) was inhibited in the presence of tunicamydn, they were considered 
different N-glycosylation forms of the same gene. The two proteins detected 
during treatment of cells with tunicamydn were considered to be the 
nonglycosylated backbone protein (20 K), as predicted from the nudeotide 
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sequence, and the nonglycosylated form from which the N-terminal signal 
peptide has been removed (Meulenberg et al., 1995), respectively. 
As previously observed (Mardassi et al., 1995; Meulenberg et al., 1995), 
there is some discrepancy between the predicted Mr of the E glycoprotein (22.4 K 
for all isolates) and the size estimated from electrophoretic mobility. In vitro 
translation studies with the European and Canadian reference strain of PRRSV 
demonstrated that the glycosylated and non-glycosylated gene product of ORF 5 
was approximately 25 and 20 K, respectively, for the European (Meulenberg et al., 
1995), and 24.5 and 18.5 K for the Canadian strain (Mardassi et al., 1995). 
Intermediate glycosylated forms of this protein were not detected in those 
experiments. However, the E glycoprotein of the European and Canadian 
isolates contain only two N-glycosylation sites (Conzelmaim et al., 1993; 
Meulenberg et al., 1993; Mardassi et al., 1995), as deduced from amino acid 
sequence analysis, in contrast to three N-glycosylation sites of the U.S. isolate of 
PRRSV (Murtaugh et al., 1995). Thus, by detecting several glycosylated forms of 
this proteins, our results indicate that all three glycosylation sites of the E 
glycoprotein of the U. S. isolate of PRRSV might be functional in vivo. Indeed, 
gene specific sera to the gene product of ORF 5 detected several form of the 
protein in PRRSV infected cells. In contrast, only the fully glycosylated form has 
been detected in purified virion preparation (Bautista et al., 1996; Meulenberg et 
al., 1995). 
Interestingly, a recent report indicated that vaccinia virus expression of 
PRRSV ORF 5 in mammalian cells induced extensive cell death (Suarez et al., 
1996) even during co-expression with the anti-apoptosis gene bcl-2. Although 
the baculovirus AcMNPV normally express an anti-apoptosis protein (Clem et 
al., 1991), the recombinant rBac-5 induced extensive cell death, in contrast to 
recombinants rBac-6 and rBac-7, or even wild type virus, suggesting that the gene 
product of ORF 5 itself was involved with cell death. Thus, it would be of 
interest to determine the pathway of cell death induced by this protein and its 
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relationship with pathogenesis during infection of animals. 
Recombinant baculovirxis-expressed protein M was larger than the M 
protein detected in cell lysates (Nelson et al., 1994), in purified LV particles 
(Meulenberg et al., 1995) or by in vitro translation of the Canadian and European 
strain of PRRSV (Mardassi et al., 1995; Meulenberg et al., 1995). Although in 
vitro translation of the LV ORF 6 yielded a 18 K protein, immunoprecipitation of 
LV M protein from infected cell lysate yielded a peptide of Mr 21.5 K (Meulenber 
et al., 1995) which is similar to the baculovirus-expressed M protein reported 
herein (Fig 3). Baculovirus-expressed N protein was similar in size to the 
protein obtained by in vitro translation studies of the ORF 7 of the European and 
Canadian isolates (Mardassi et al., 1995; Meulenberg et al., 1995) and to the 
putative N protein detected in infected cell lysates (Nelson et al., 1994; fig 2 (E, F)). 
The lower levels of recombinant baculovirus-expressed M protein observed in 
this experiment, in comparison to the N protein, might be accounted for by the 
presence of membrane anchoring domain(s) in the this proteins which might 
prevent higher level of recombinant protein expression in insect cells. 
Monospecific sera to recombinant-baculovirus expressed M and N proteins 
recognized a single peptide in MARC-145 infected cells, with Mr of 
approximately 18 K and 15 K, respectively. 
The proteins expressed and characterized in this study are similar in size 
to the proteins recently detected and characterized in purified virion preparation 
(Bautista et al., 1996). By inference to the nucleotide sequence it was concluded 
that the 26-30 K, 19 K and 15 K polypeptides corresponded to the product of ORF 5 
(E), 6 (M) and 7 (N), respectively. Indeed, as determined in our experiments, the 
ORF 5, 6 and 7 encode for the viral E, M and N proteins, respectively 
A recent serologic survey indicated that most animals develop an antibody 
response reactive to both European and U.S. strain of PRRSV (Bautista et al., 
1993). In addition, it has been demonstrated that the M and N proteins are 
highly conserved among U.S. isolates of PRRSV and M is the most conserved 
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protein between U.S. and European isolates (Meng et al., 1995a). Thus, these 
proteins might be a useful target for the development of assays for serological 
detection of infected animals. Indeed, all but one serum sample collected weekly 
over a period of more than 3 months from a pig congerutally infected with 
PRRSV were positive by western blot against protein M. Thus, these 
experiments indicated the potential of the recombinant protein M, or the 
nudeocapsid protein N, as target antigen in serological assays to detect PRRSV 
infection. In addition, monospecific antibodies to the N protein were found 
highly reactive and useful in IFA assays, even with the Lelystad virus. 
In conclusion, the baculovirus-expressed proteins E, M and N of an U.S. 
isolate of PRRSV were similar in size to the proteins of the European and 
Canadian isolates, and antigenically similar to the native proteins. Because we 
were able to detected all predicted N-glycosylated forms of the glycoprotein E, the 
baculovirus system might be useful for the expression and characterization of 
other PRRSV glycoproteins that have only recently been suggested to play a role 
in virus structvire. In addition, these system might be used for the large scale 
production of serodiagnostic reagents. 
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Figtire 1. Schematic representation, of the clorung strategy. Total RNA from 
PRRSV-infected cells was used in a RT-PCRa reaction to amplify 
each gene. Each primers (see below) was designed to contain a 
restriction site (EcoRI or BamHI, underlined) at the 5' end to 
facilitate cloning into the transfer vector. The 5' end primer for 
each ORF (A, C, and E) contained the ATG initiation codon of the 
ORF (in bold). The amplified fragment containing the complete 
sequence for each gene was digested with BamHI and EcoRI and 
ligated into the transfer vector pVL 1393 digested with the same 
enzymes. The recombinant vector was then transfected into insect 
cells along with linearized baculovirus DNA. The primers 
sequence was based on isolate VR 2385 (ref. 10) 
A: GCCnCCGGATCCATGTTGGGGAAATGCITG 
B: GCCGCCGAATICGAGCCGTGCTATCATGAC 
C: GCCGCCGGATCCAATGGAGTCGTCCTTAGA 
E: GCCGCCGGATCCAATATGCCAAATAACACC 
F: GCCGCCGAATTCATGCCTCAAGAATGCCAG 
RT-PCR conditions were: 1 hr at 56 C, 5 min at 95 C for the RT 
reaction, followed by 25 cycles of denaturation at 94 C for 10 sec, 
annealing at 50 C for 30 sec, extension at 72 C for 30 sec, and a final 
elongation step of 10 min at 72 C. 
AcMNPV = Autographa califomica nuclear polyhedrosis virus 
PH = polyhedrin promoter 
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Figure 2. Synthesis and processing of baciilovirus-expressed PRRSV 
proteins. (A) Western blot analysis of crude lysates from insect 
cells expressing the E glycoprotein, collected at 12,24 or 48 hours 
p.i., as indicated on the top of the figure. (B) Effect of tunicamycin 
treatment on baculovirus-expressed glycoprotein E. 
Insect cells were infected in the absence (c) or presence (t) of 
4 ug/ml of tunicamycin, and collected at 48 hours p.i. NI, non-
infected cells. (C) Coomassie blue staining of SDS-PAGE from 
non-infected (NI) or rBac-6 infected insect cells collected at 12, 24 
or 48 hours pi. Arrow indicates the recombinant M protein. 
(D) Western blot of replica gel, as stated in C. (E) Coomassie blue 
staining of insect cell lysates non-infected (NI) or infected with 
rBac-7, collected at 1,12,24,48 or 96 hours p.i. (F) Replica 
immunoblot analysis of E. The position of markers is indicated at 
right. Molecular weight standards are indicated at right 
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Figure 3. Western blot reactivity of porcine sera to baculovirus-expressed 
recombinant (A) M and (B) N proteins. Sera samples were 
collected from a piglet congenitally infected with PRRSV. Lane 
1, serum collected at birth (pre-suckling); lanes 2 to 16, sera 
collected at weekly intervals from 7 to 105 days of age, 
respectively. The position of molecular weight markers is 
indicated at right. 
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Figure 4. Western blot identification of proteins encoded by ORFs 5,6 and 7 in 
PRRSV infected MARC-145 cells. Infected or noninfected cells were 
separated by SDS-PAGE and blotted to nitrocellulose membranes. 
Strips were reacted with sera from rabbits immunized with the protein 
expressed by rBac-5 (E), rBac-6 (M) or rBac-7 (N) collected prior to 
immunization (pre-5, pre-6 and pre-7), or their corresponding post 
immimization sera (anti-5, anti-6 and anti-7, respectively). Strips from 
noninfected (NI) cells were reacted with a pool of anti-5,6 and 7. The 
position of the reactive proteins (E, M and N) is indicated by arrows. 
The position of molecular weight standard markers is indicated at 
right. 
Figure 5. Detection of PRRSV proteiris by indirect fluorescent antibody 
staining of MARC-145 irifected cells. Cells were grown in 8-well 
chambers and fixed 20 hr p.i. for immunostaining. Porcine anti-
PRRSV hyperimmune sera was used to immunostain (A), MARC-
145 infected or (B), non-ir\fected MARC-145 ceils. (C) MARC-145 
noninfected cells stained with a pool of rabbit post immunization 
sera. (D) PRRSV-infected MARC-145 cells reacted with anti-5, 
(E) anti-6 or (F) anti-7 sera. Notice the intracellular location of each 
protein, indicated by arrows. E and M are located in the 
perinuclear area whereas N is distributed throughout the 
cytoplasm. 
» . » r 
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CHAPTER 6. GENERAL CONCXUSIONS 
The experimental work outlined in this dissertation aimed to investigate 
one specific area of PRRSV biology, namely, the iiutial stages of virus infection of 
cells, which includes virus binding, entry and uncoating. Although these steps 
are the very beginning of the virus replication cycle, their investigation has been 
usually neglected, even for other virus-cell systems. 
Initially, because no iiiformation relating the entry process of any 
arterivirus was available, it was assumed that PRRSV could enter the cells by 
either fusing the envelope at the ceil membrane, or by receptor-mediated 
endocytosis wherein a low endosomal pH could also be required. Thus, a series 
of experiments were performed, using infectivity and inhibition studies and 
immunoelectron microscopy, to accurately determine the pathway of PRRSV 
entry into cells. Collectively, the data indicated that PRRSV entry occurred 
through a microfilament-dependent, endocytic mechanism wherein a low pH 
was required to allow infection of cells. This conclusion was drawn based on the 
following observation. 1) The effect of chloroquine and Bafilomycin A1 on the 
vinis yield from infected cells or in the number of infected cells, respectively, 
was dose-dependent. 2) That chloroquine and Bafilomycin A1 affected an early 
step of virus replication was determined by measuring the amount of viral RNA 
during infection of cells. In this system, replication of viral RNA is perhaps the 
earliest event following infection of cells that can currently be detected. One 
could assume that these drugs inhibited RNA replication, however, additional 
data (see # 3 below) indicated that RNA replication was not inhibited. 3) The 
effect of chloroquine or Bafilomycin A1 on virus yield from infected cells or the 
number of irifected cells was at its most when added to the cells prior to or soon 
after infection, and was negligible (for chloroquine) and decreased (>70% for 
Bafilomycin Al) when added after 1 hr p.i. This indicated that these drugs had 
no effect on later steps of virus replication, as for example RNA replication. 
4) Electron microscopy of the initial stages of virus infection of cells 
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demonstrated virus particles at the cell surface, or entering cells through vesicles 
surrounded by a clathrin-like zone, but not fusing at the cell surface. 5) Infection 
of cells by PRRSV was inhibited by cytochalasin B and phenylarsine oxide, which 
usually inhibit cellular microfilament movement and endocytosis, respectively. 
Thus, these results strongly suggests that PRRSV entry into cells occurs via the 
endocytic pathway and that a low pH is required for the subsequent step; 
consequently, we concluded that PRRSV belongs to the pH-dependent group of 
viruses. 
Early reports on PRRS outbreaks suggested that the syndrome was caused 
by an infectious agent and, consequently, there was an intensive search for a 
microorganism that could reproduce the disease experimentally. Eventually, a 
virus (PRRSV) was isolated in porcine alveolar macrophages and its role in the 
disease process defined. Currently, PRRSV replication has been detected only in 
a limited number of cells. Thus, it would be of interest to investigated whether 
virus replication could be restricted by early events of virus infection of cells. 
Virus infection of cells can be restricted at any step such as binding to proper cell 
surface molecules, internalization, uncoating, genome replication and 
expression, virus assembly and exit from the cells. Most reports on lack of 
PRRSV replication in a variety of cells has been determined only by the presence 
of cytophatic effect following attempts to isolated the virus or by measuring virus 
yield from these cells. To investigate the mechanisms that prevent PRRSV 
replication in a variety of cells from different animal origins, my approach was to 
investigate whether virxis could bind, enter and induce synthesis of viral 
proteins in these cells. Taken together, the results from this set of experiments 
indicated that restriction of PRRSV replication resides mainly at the cell 
membrane level; this conclusion was obtained from the following data. 
1) Binding experiments indicated that a variety of cells (BHK-21, CRFK, HaK, 
MDBK, MDCK, PK-15, and ST) do not bind PRRSV, and consequendy, virus 
entry and replication could not detected. However, Vero cells, which have the 
same origin (monkey kidney) as the permissive cells used as control in these 
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experiments (MARC-145 cells), bound and internalized PRESV almost as 
efficiently as MARC-145 cells, but did not support virus replication, as measured 
by IFA staining of cells. Furthermore, Vero cells internalized PRRSV as an 
infectious virion, which is consistent with a mechanism that does not remove 
the viral envelope, e.g. receptor-mediated endocytosis, as indicated in the 
previous work. Thus, these results pointed towards cell membrane-assodated 
factors as the cause of resistance to infectioru 2) That the resistance to PRRSV 
replication was indeed occurring at the cell membrane level, at least in some 
cells, was demonstrated by tranfecting cells with viral RNA, which induced the 
generation of virus particles, indicating that the intracellular milieu of those 
cells were fully permissive to PRRSV replication. However, some cells did not 
produce infectious virus particles which might suggest several other possibilities, 
a) The transfection condition were not ideal for those cells, consequently the 
viral RNA was not introduced into the cells, b) Replication of viral RNA might 
have been inhibited by intracellular factors, c) The intracellular milieu of this 
cells did not allow proper virus assembly and release from the cells, d) The cells 
produced non-infectious virus particles which were not detected in the 
subsequent assay. 
Because of the difficulties involving transfection of mammalian cells with 
RNA (or even DNA molecules), investigation of each of these hypothesis might 
prove laborious and time consuming, and its significance to the field can not be 
predicted, mainly because PRRSV does not bind and enter those cells under 
physiologic conditions. However, further investigation of the mechanism that 
restricts PRRSV replication in Vero cells is recommended, maiiUy because it 
could point towards determining the exact cellular components that are required 
to support PRRSV entry, uncoating and replication. Because PRRSV replicates 
in Vero cells following PEG treatment of cell-bound virus or transfection of viral 
RNA, my hypothesis is that Vero cells are defective in a particular component 
that does not allow PRRSV to become uncoated and therefore initiate 
replication. It is very tempting and appropriate, at this time, to discuss several 
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observations and possibilities concerning the likely mechanism of PRRSV entry 
and uncoating. 1) comparing binding and entry of PRRSV in MARC-145 and 
Vero cells, it is suggestive that Vero cells are defective in virus uncoating, 
indicating that this is a multifactorial event. 2) The multiplicity of factors 
involved suggests the following possibilities, a) PRRSV binding, entry and 
uncoating is mediated by more than one viral protein that interacts with more 
than one cellular component, one of which is absent in Vero cells, b) One or 
more viral protein(s) interact with a single cellular component, which is partially 
defective in Vero cells, c) A single viral protein interact with more that one 
cellular component to mediate entry, but one of the cellular component is not 
functional in Vero cells. Identifying these components will represent a major 
steps towards understanding PRRSV tropism, replication and pathogenesis. 
The experimental work outlined in the third manuscript included in this 
dissertation was aimed to identify the viral structures involved in virus-cell 
interaction. The state of knowledge on the moleaalar aspects of PRRSV at the 
time the experiments were initiated were not even comparable with what is 
currentiy known. At that time, the partial nucleotide sequence (for ORFs 5, 6 
and 7) of only one U.S. isolate of PB^RSV had just been published (Meng et al., 
1994), and little information was available on the structural proteins of the virus 
(Nelson et al., 1994), Nonetheless, ORFs 5, 6 and 7 of a different isolate from 
which the sequence was obtained were amplified by RT-PCR and cloned into a 
baculovirus expression vector. The main goal, as mentioned above, was to use 
the recombinant proteins to determine which one would interact with cellular 
receptors. The baculovirus expression system was chosen because it is thought to 
synthesize and process proteins similarly to mammalian cells, with the 
advantage of higher level of expression driven by the strong polyhedrin 
promoter. In addition, the proteins could be used for the production of 
serodiagnostic reagents. 
Successful expression and detection of the proteins encoded by these ORFs 
was obtained, as demonstrated in result section of the manuscript. In addition, it 
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was possible to use this proteins to induce gene-specific polyclonal sera that was 
then used to detect the proteins expressed in mammalian cells following 
infection with the PRRSV and to indicate their intracellular location. Although 
several attempts were made, we were not able to demonstrate which of these 
proteins interact with cellular receptors. Discussion of the possible reasons that 
prevented us from detecting the protein(s) that bind to cells will be more 
emphasized herein, rather than the positive results that we obtained with those 
experiments. 
The proteins encoded by ORFs 5, 6 and 7 (E, M and N, respectively) were 
expressed in insect cells by a recombinant baculovirus and their specificity 
characterized by their reactivity, in western blots, to sera from an experimentally 
PRRSV-infected pig. One interesting feature observed during expression of the 
recombinant proteins was the strong association of E and M with intracellular 
membranes following gentle disruption of cells (i.e. to remove the cytoplasmic 
membrane). This was also observed with the native E and M proteins expressed 
during viral infection of mammalian cells and has been recently reported in the 
literature (Mardassi et al., 1996). Several experiments attempting to demonstrate 
binding of these proteins to mammalian cells were performed. All binding 
experiments were performed as follow. 1) The proteins were purified by 
electroelution from SDS-PAGE, incubated in renaturing buffers, biotinylated and 
then used in binding assays with MARC-145 cells. SDS-PAGE analysis of the 
protein content indicated that all recombinant purified proteins become 
biotinylated but did not bind to MARC-145 cells. Similarly, nonbiotinylated 
recombinant proteins were used in an attempt to prevent PRRSV from binding 
and replicating in MARC-145 cells. No inhibition of virus replication was 
obtained even with 100 ng/ml of protein. 2) A partially purified extract of insect 
ceUs enriched for the recombinant protein (nondenatured at any step) was also 
biotinylated and used in binding experiments, and a nonbiotinylated fraction was 
used in virus infectivity inhibition assays. None of the proteins bound or 
inhibited virus infection of cells. 3) Biotinylated and nonbiotinylated proteins 
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were used in a modification of the virus overlay protein binding assays 
(VOPBA); in this case, only the recombinant proteins were used to determine if 
any could bind to MARC-145 cell membrane extracts that had been separated by 
SDS-PAGE, blotted to nitrocellulose and renatured by established protocols. 
Again, no binding could be demonstrated. 4) Polyclonal antibodies to the 
recombinant proteins were characterized by western blot and IFA assays (see last 
manuscript of the thesis). None of the proteins (E, M or N) induced neutralizing 
antibodies as tested by serum neutralization assay using MARC-145 cells and the 
virus firom which the ORFs were cloned. Limited information has been recently 
reported that the protein encoded by ORF 5, after electroelution from gels and 
subsequent injection into the spleen of pigs, induced neutralizing antibodies 
(Persch et al., 1995). In addition, based on the similarities of PRRSV with other 
arteriviruses (Plagemann, 1996), there is enough evidence suggesting an 
important role of the E and perhaps also the M proteins in virus cell interaction. 
Failure to detect binding could be attributed to several reasons, a) The 
binding site (domain) of the putative binding protein might be formed by 
conformation epitopes that were not renatured by the renaturation buffer and 
consequently did not bind to the ceils, b) The strong association of the 
recombinant proteins with intracellular membranes prevented binding. 
c) Because E and M are found linked by disulfide bonds in the surface of the 
virion (Mardassi et al., 1996), it is possible that a proper folding and interaction of 
E and M is necessary to confer binding ability, d) It is possible that other viral 
structural proteins are also involved in virus cells interaction and would be 
required to allow binding of E or M to the cells, e) Binding of viral proteins 
require that they be presented in a specific structural form that is only found in 
the virion, f) Lack of neutralizing activity in the polyclonal sera produced 
against the baculovirus-expressed recombinant glycoprotein E, in contrast to the 
results obtained by others (Persch et al., 1995), might have been due to the 
different route of inoculation (intrasplenic versus intramuscular), different 
animal used to induce antibodies (swine versus rabbits), or other aspects of the 
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immunization protocol as for example antigen dose, adjuvant(s) used and 
nimiber of boosting injection/lenght of immunization (no details available from 
Persch et al., 1995 regarding these aspects of the protocol). 
Although we could not identify the viral protein that mediates binding to 
cellular receptors, cloning and expression of the PRRSV ORFs 5, 6 and 7 provided 
valuable information on the proteins themselves and their potential use for 
serodiagnostic of PRRSV infection. For instance, baculovirus expression of 
ORF 5 demonstrated the different glycosylated forms of the E glycoprotein, which 
had been previously predicted only by amino acid sequence analysis, and 
indicated the potential of the baculovirus system for the expression of other 
PRRSV glycoproteins. In addition, polyclonal sera produced against E, M and N 
proteins were useful to determine their intracellular location in mammalian 
cells following virus infection. Furthermore, polyclonal sera against the 
recombinant N protein reacted strongly with the native protein of the U.S. 
isolate and also reacted with the Lelystad virus protein (the European isolate 
prototype) by IFA assay, indicating its value in diagnostic applications. 
Porcine reproductive and respiratory syndrome virus is considered an 
emerging virus. As such, there are several important features of the virus and 
the disease it causes that require investigation. The most intriguing, perhaps, are 
related to the virus emergence in the swine population and its ability to persist 
in the infected animal. A few steps have been taken in this direction: unlike 
previously hypothesized, PRRSV is no more related to LDV than to other 
members of the arterivirus group (Kapur et al., 1996). Viral RNA has been 
detected in cells from an infected animals when, at the same time, antigen was 
not detected (Sur et al., 1996), suggesting the possibility of RNA persistence. The 
yet unanswered questions related to the experimental work outlined in this 
dissertation are those concerning virus-cell interaction: for instance, what are the 
viral protein(s) that mediate binding to cells? Is binding to porcine macrophage 
mediated by the same structures that mediate binding to continuous cell lines? Is 
there a specific fusogenic domain that mediates fusion and entry? What is/are 
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the cellular receptor(s) for the virus in MARC-145 cells and porcine alveolar 
macrophages? Based on the observation of PRRSV interaction with Vero cells, 
what are the requirement for virus uncoating? Does an intracellular block to 
PRRSV replication exist? Following virus entry, how is the viral RNA released 
from the nudeocapsid? Is there a requirement for myiistoylation or 
phosphorylation of the nudeocapsid protein during uncoating? There is no 
doubt that answering these questions will represent a major step towards 
understanding the pathogenesis of PRRSV. 
The experimental work of this dissertation was directed to understand 
interaction of PRRSV with cells. Taken together, the results that have been 
obtained allow us to draw a few general condusions. a) The resistance of cells in 
culture to PRRSV replication is determined mainly by cell membrane-assodated 
factors, b) The genome of PRRSV is indeed of positive molarity and 
consequently, infectious per se. c) PRRSV enters cells by receptor-mediated 
endocytosis in which a low pH is required, consequently, PRRSV belongs to the 
pH-dependent group of virus; d) the major structural proteins of PRRSV 
(i.e. E, M and N) are located at specific intracellular compartments during virus 
infection of cdls, which might have major consequences on the mechanism of 
persistence and induction of cell-mediated immunity. Investigation of the 
initial stages of PRRSV interaction with cells, taken the above mentioned 
questions as a starting point, is highly recommended to better define PRRSV and 
the syndrome it causes, which still is, somehow, a "mystery disease of pigs". 
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